Term	Accession	Genes (tot)	Stat (non-dir.) p	p adj (non-dir.)	Significant..in.gene.set.	Non.significant..in.gene.set.	Significant..not.in.gene.set.	Non.significant..not.in.gene.set.	effect.size
R-HSA-109606	Intrinsic Pathway for Apoptosis	 40	0.37384499460542	0.713080369766776	19	21	7515	9657	1.08517387841784
R-HSA-109688	Cleavage of Growing Transcript in the Termination Region 	 58	0.0016593838809525	0.0298689098571449	37	21	7497	9657	1.45740230495318
R-HSA-109703	PKB-mediated events	 39	0.00328207685507626	0.0475055247889388	26	13	7508	9665	1.52305105742855
R-HSA-109704	PI3K Cascade	 69	0.0222339713289573	0.14903436469765	39	30	7495	9648	1.29128241825464
R-HSA-110056	MAPK3 (ERK1) activation	 10	0.0883599329364341	0.30936993975749	7	3	7527	9675	1.59920361029997
R-HSA-110312	Translesion synthesis by REV1	 15	0.0637194926441077	0.25856117824372	10	5	7524	9673	1.52305105742855
R-HSA-110313	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template	 36	0.277728703317073	0.616979587748688	18	18	7516	9660	1.14228829307141
R-HSA-110314	Recognition of DNA damage by PCNA-containing replication complex	 27	0.149013553025479	0.429599647736698	15	12	7519	9666	1.26920921452379
R-HSA-110320	Translesion Synthesis by POLH	 18	0.0139835417912783	0.121190695524412	13	5	7521	9673	1.64997197888093
R-HSA-110328	Recognition and association of DNA glycosylase with site containing an affected pyrimidine	  8	0.0151772407427947	0.125346152958139	7	1	7527	9677	1.99900451287497
R-HSA-110329	Cleavage of the damaged pyrimidine 	  8	0.0151772407427947	0.125346152958139	7	1	7527	9677	1.99900451287497
R-HSA-110357	Displacement of DNA glycosylase by APEX1	  9	0.00739667387636194	0.0824200803366045	8	1	7526	9677	2.03073474323806
R-HSA-110362	POLB-Dependent Long Patch Base Excision Repair	  8	0.0151772407427947	0.125346152958139	7	1	7527	9677	1.99900451287497
R-HSA-110373	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	 24	0.109196175396028	0.342213013964338	14	10	7520	9668	1.33266967524998
R-HSA-111367	SLBP independent Processing of Histone Pre-mRNAs	  9	0.832520764277791	1	3	6	7531	9672	0.761525528714273
R-HSA-111447	Activation of BAD and translocation to mitochondria 	 15	0.0637194926441077	0.25856117824372	10	5	7524	9673	1.52305105742855
R-HSA-111448	Activation of NOXA and translocation to mitochondria	  5	0.725062616235642	1	2	3	7532	9675	0.913830634457128
R-HSA-111453	BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members	  8	0.494285327120202	0.836116384670799	4	4	7530	9674	1.14228829307141
R-HSA-111465	Apoptotic cleavage of cellular proteins	 32	0.702307582923369	1	13	19	7521	9659	0.92810923812052
R-HSA-111885	Opioid Signalling	 77	0.0593583043310966	0.248032914526368	41	36	7493	9642	1.21646285755657
R-HSA-111931	PKA-mediated phosphorylation of CREB	 20	0.711346076027641	1	8	12	7526	9666	0.913830634457128
R-HSA-111932	CaMK IV-mediated phosphorylation of CREB	  5	0.119239284310492	0.361580896699634	4	1	7530	9677	1.82766126891426
R-HSA-111933	Calmodulin induced events	 28	0.459918805163339	0.80364685713825	13	15	7521	9663	1.06069627213774
R-HSA-111957	Cam-PDE 1 activation	  6	0.533523591186547	0.869215486173459	3	3	7531	9675	1.14228829307141
R-HSA-111996	Ca-dependent events	 30	0.443177360892993	0.792638235278678	14	16	7520	9662	1.06613574019998
R-HSA-111997	CaM pathway	 28	0.459918805163339	0.80364685713825	13	15	7521	9663	1.06069627213774
R-HSA-112040	G-protein mediated events	 45	0.521132010034835	0.869215486173459	20	25	7514	9653	1.01536737161903
R-HSA-112043	PLC beta mediated events	 44	0.588880656669355	0.925646804661546	19	25	7515	9653	0.986521707652581
R-HSA-112308	Presynaptic depolarization and calcium channel opening	 12	0.232913396149656	0.550864040284059	7	5	7527	9673	1.33266967524998
R-HSA-112310	Neurotransmitter release cycle	 46	3.23353236520187e-05	0.00302658629382895	34	12	7500	9666	1.68860008540991
R-HSA-112311	Neurotransmitter clearance	  9	0.955061166788585	1	2	7	7532	9671	0.507683685809515
R-HSA-112382	Formation of RNA Pol II elongation complex 	 50	0.0550573091564467	0.240514003210775	28	22	7506	9656	1.27936288823998
R-HSA-112409	RAF-independent MAPK1/3 activation	 23	0.074965757517953	0.284464658257313	14	9	7520	9669	1.39061183504346
R-HSA-112411	MAPK1 (ERK2) activation	  9	0.0424092247753092	0.20391284789224	7	2	7527	9676	1.7768929003333
R-HSA-113418	Formation of the Early Elongation Complex	 27	0.0138723286327914	0.121190695524412	18	9	7516	9669	1.52305105742855
R-HSA-113501	Inhibition of replication initiation of damaged DNA by RB1/E2F1	 12	0.232913396149656	0.550864040284059	7	5	7527	9673	1.33266967524998
R-HSA-113507	E2F-enabled inhibition of pre-replication complex formation	  8	0.237373749552604	0.550864040284059	5	3	7529	9675	1.42786036633926
R-HSA-113510	E2F mediated regulation of DNA replication	 20	0.108246273291187	0.342213013964338	12	8	7522	9670	1.37074595168569
R-HSA-114452	Activation of BH3-only proteins	 30	0.305467150713263	0.657785091413223	15	15	7519	9663	1.14228829307141
R-HSA-114508	Effects of PIP2 hydrolysis	 25	0.15120514741184	0.430549981996921	14	11	7520	9667	1.27936288823998
R-HSA-114516	Disinhibition of SNARE formation	  5	0.119239284310492	0.361580896699634	4	1	7530	9677	1.82766126891426
R-HSA-114604	GPVI-mediated activation cascade	 48	0.97272258972122	1	15	33	7519	9645	0.713930183169631
R-HSA-1169091	Activation of NF-kappaB in B cells	 58	0.0531067825359705	0.239748947525732	32	26	7502	9652	1.26045604752707
R-HSA-1169092	Activation of RAS in B cells	  5	0.725062616235642	1	2	3	7532	9675	0.913830634457128
R-HSA-1169408	ISG15 antiviral mechanism	 65	0.22203246770857	0.550766050641046	32	33	7502	9645	1.12471462702416
R-HSA-1169410	Antiviral mechanism by IFN-stimulated genes	 65	0.22203246770857	0.550766050641046	32	33	7502	9645	1.12471462702416
R-HSA-1170546	Prolactin receptor signaling	 12	0.0958686086119971	0.324375228379729	8	4	7526	9674	1.52305105742855
R-HSA-1181150	Signaling by NODAL	 17	0.673674387554733	0.984223558924917	7	10	7527	9668	0.940708006058808
R-HSA-1187000	Fertilization	 11	0.923876742706931	1	3	8	7531	9670	0.623066341675314
R-HSA-1221632	Meiotic synapsis	 47	0.885470900742938	1	17	30	7517	9648	0.826336212009105
R-HSA-1222556	ROS, RNS production in phagocytes	 27	0.0350068483079032	0.182804057271934	17	10	7517	9668	1.43843710979363
R-HSA-1226099	Signaling by FGFR in disease	 55	0.0703694649088785	0.276553823399698	30	25	7504	9653	1.24613268335063
R-HSA-1227986	Signaling by ERBB2	 45	0.00966337676021967	0.0975093761272612	28	17	7506	9661	1.42151432026664
R-HSA-1234158	Regulation of gene expression by Hypoxia-inducible Factor	 10	0.886172703573919	1	3	7	7531	9671	0.685372975842846
R-HSA-1234174	Regulation of Hypoxia-inducible Factor (HIF) by oxygen	 64	0.264268331248872	0.595558165446897	31	33	7503	9645	1.10659178391293
R-HSA-1234176	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	 56	0.141117893762141	0.415365875979132	29	27	7505	9651	1.18308430353825
R-HSA-1236382	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	 17	0.00647143831494953	0.0744745851982717	13	4	7521	9674	1.74702915410921
R-HSA-1236394	Signaling by ERBB4	 37	0.0078407991127856	0.0860037652683671	24	13	7510	9665	1.48188751533588
R-HSA-1236973	Cross-presentation of particulate exogenous antigens (phagosomes)	  7	0.982247180832935	1	1	6	7533	9672	0.326368083734688
R-HSA-1236974	ER-Phagosome pathway	 70	0.511495565547858	0.856968704092115	31	39	7503	9639	1.01174105957753
R-HSA-1236975	Antigen processing-Cross presentation	 82	0.70201737751895	1	34	48	7500	9630	0.947263462547023
R-HSA-1236977	Endosomal/Vacuolar pathway	  8	0.92782996623063	1	2	6	7532	9672	0.571144146535705
R-HSA-1236978	Cross-presentation of soluble exogenous antigens (endosomes)	 40	0.37384499460542	0.713080369766776	19	21	7515	9657	1.08517387841784
R-HSA-1237044	Erythrocytes take up carbon dioxide and release oxygen	 10	0.886172703573919	1	3	7	7531	9671	0.685372975842846
R-HSA-1237112	Methionine salvage pathway	  5	0.384410212719386	0.713080369766776	3	2	7531	9676	1.37074595168569
R-HSA-1247673	Erythrocytes take up oxygen and release carbon dioxide	  6	1	1	0	6	7534	9672	0
R-HSA-1250196	SHC1 events in ERBB2 signaling	 19	0.0709112367691535	0.276553823399698	12	7	7522	9671	1.44289047545862
R-HSA-1250342	PI3K events in ERBB4 signaling	  8	0.237373749552604	0.550864040284059	5	3	7529	9675	1.42786036633926
R-HSA-1250347	SHC1 events in ERBB4 signaling	 12	0.0958686086119971	0.324375228379729	8	4	7526	9674	1.52305105742855
R-HSA-1251985	Nuclear signaling by ERBB4	 21	0.0732464862615547	0.280799596292811	13	8	7521	9670	1.41426169618365
R-HSA-1253288	Downregulation of ERBB4 signaling	  7	0.365829538336403	0.703595440855219	4	3	7530	9675	1.30547233493875
R-HSA-1268020	Mitochondrial protein import	 54	6.88954040222255e-05	0.00419151113715512	38	16	7496	9662	1.60766500506347
R-HSA-1295596	Spry regulation of FGF signaling	 15	0.0201807664511104	0.140964159688353	11	4	7523	9674	1.6753561631714
R-HSA-1296041	Activation of G protein gated Potassium channels	 22	0.0485079765817369	0.22626312000252	14	8	7520	9670	1.45382146390907
R-HSA-1296052	Ca2+ activated K+ channels	  8	0.92782996623063	1	2	6	7532	9672	0.571144146535705
R-HSA-1296059	G protein gated Potassium channels	 22	0.0485079765817369	0.22626312000252	14	8	7520	9670	1.45382146390907
R-HSA-1296065	Inwardly rectifying K+ channels	 27	0.149013553025479	0.429599647736698	15	12	7519	9666	1.26920921452379
R-HSA-1296071	Potassium Channels	 86	0.752466233397101	1	35	51	7499	9627	0.929769540872078
R-HSA-1296072	Voltage gated Potassium channels	 37	0.81389270104085	1	14	23	7520	9655	0.864434383945932
R-HSA-1296346	Tandem pore domain potassium channels	 10	0.972283282592251	1	2	8	7532	9670	0.456915317228564
R-HSA-1306955	GRB7 events in ERBB2 signaling	  5	0.119239284310492	0.361580896699634	4	1	7530	9677	1.82766126891426
R-HSA-1358803	Downregulation of ERBB2:ERBB3 signaling	 12	0.0292250203990059	0.174004233879745	9	3	7525	9675	1.71343243960711
R-HSA-1362277	Transcription of E2F targets under negative control by DREAM complex	 16	0.595758040689229	0.931452437781378	7	9	7527	9669	0.999502256437483
R-HSA-1362300	Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1	 15	0.706996874102752	1	6	9	7528	9669	0.913830634457128
R-HSA-1362409	Mitochondrial iron-sulfur cluster biogenesis	 12	0.232913396149656	0.550864040284059	7	5	7527	9673	1.33266967524998
R-HSA-1368071	NR1D1 (REV-ERBA) represses gene expression	  7	0.659294130824154	0.97498346054538	3	4	7531	9674	0.979104251204065
R-HSA-1368082	RORA activates gene expression	 27	0.0350068483079032	0.182804057271934	17	10	7517	9668	1.43843710979363
R-HSA-1368108	BMAL1:CLOCK,NPAS2 activates circadian gene expression	 44	0.0989258139437467	0.330697456034919	24	20	7510	9658	1.24613268335063
R-HSA-1369062	ABC transporters in lipid homeostasis	 15	0.311123401495976	0.661844326818712	8	7	7526	9671	1.21844084594284
R-HSA-139853	Elevation of cytosolic Ca2+ levels	 13	0.744068200022459	1	5	8	7529	9670	0.878683302362623
R-HSA-139915	Activation of PUMA and translocation to mitochondria	  9	0.955061166788585	1	2	7	7532	9671	0.507683685809515
R-HSA-140342	Apoptosis induced DNA fragmentation	 12	0.846156869006207	1	4	8	7530	9670	0.761525528714273
R-HSA-140534	Ligand-dependent caspase activation	 16	0.991420794489887	1	3	13	7531	9665	0.428358109901779
R-HSA-140837	Intrinsic Pathway of Fibrin Clot Formation	 16	0.898402239592885	1	5	11	7529	9667	0.713930183169631
R-HSA-140875	Common Pathway of Fibrin Clot Formation	 18	0.984491160706561	1	4	14	7530	9664	0.507683685809515
R-HSA-140877	Formation of Fibrin Clot (Clotting Cascade)	 30	0.983120020408287	1	8	22	7526	9656	0.609220422971418
R-HSA-141405	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	 17	0.0678039646689028	0.268159905338421	11	6	7523	9672	1.47825543809241
R-HSA-141424	Amplification of signal from the kinetochores	 72	0.117985984637573	0.361580896699634	37	35	7497	9643	1.1740185234345
R-HSA-141430	Inactivation of APC/C via direct inhibition of the APC/C complex	 17	0.0678039646689028	0.268159905338421	11	6	7523	9672	1.47825543809241
R-HSA-141444	Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal	 72	0.117985984637573	0.361580896699634	37	35	7497	9643	1.1740185234345
R-HSA-1433559	Regulation of KIT signaling	 15	0.706996874102752	1	6	9	7528	9669	0.913830634457128
R-HSA-1433617	Regulation of signaling by NODAL	  9	0.349821097790456	0.703404953699137	5	4	7529	9674	1.26920921452379
R-HSA-1442490	Collagen degradation	 51	0.914759993470147	1	18	33	7516	9645	0.806321148050407
R-HSA-1445148	Translocation of GLUT4 to the plasma membrane	 67	0.00138304838425564	0.0270243833080872	42	25	7492	9653	1.43212263608953
R-HSA-1461957	Beta defensins	  5	1	1	0	5	7534	9673	0
R-HSA-1461973	Defensins	  9	0.99439105636385	1	1	8	7533	9670	0.253841842904758
R-HSA-1474151	Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation	 12	0.438356178848967	0.788030825997375	6	6	7528	9672	1.14228829307141
R-HSA-1474165	Reproduction	 11	0.923876742706931	1	3	8	7531	9670	0.623066341675314
R-HSA-1474290	Collagen formation	 76	0.738207007398312	1	31	45	7503	9633	0.93186676540036
R-HSA-1475029	Reversible hydration of carbon dioxide	 11	0.923876742706931	1	3	8	7531	9670	0.623066341675314
R-HSA-1480926	O2/CO2 exchange in erythrocytes	 10	0.886172703573919	1	3	7	7531	9671	0.685372975842846
R-HSA-1482788	Acyl chain remodelling of PC	 20	0.711346076027641	1	8	12	7526	9666	0.913830634457128
R-HSA-1482798	Acyl chain remodeling of CL	  6	0.235296834252223	0.550864040284059	4	2	7530	9676	1.52305105742855
R-HSA-1482801	Acyl chain remodelling of PS	 16	0.898402239592885	1	5	11	7529	9667	0.713930183169631
R-HSA-1482839	Acyl chain remodelling of PE	 23	0.743010951334256	1	9	14	7525	9664	0.893964751099364
R-HSA-1482922	Acyl chain remodelling of PI	 13	0.744068200022459	1	5	8	7529	9670	0.878683302362623
R-HSA-1482925	Acyl chain remodelling of PG	 14	0.80862918746242	1	5	9	7529	9669	0.815920209336721
R-HSA-1483115	Hydrolysis of LPC	  6	0.533523591186547	0.869215486173459	3	3	7531	9675	1.14228829307141
R-HSA-1483148	Synthesis of PG	  8	0.237373749552604	0.550864040284059	5	3	7529	9675	1.42786036633926
R-HSA-1483166	Synthesis of PA	 32	0.106832539485152	0.342213013964338	18	14	7516	9664	1.28507432970534
R-HSA-1483191	Synthesis of PC	 24	0.497392044456026	0.838341453080745	11	13	7523	9665	1.04709760198213
R-HSA-1483213	Synthesis of PE	 12	0.232913396149656	0.550864040284059	7	5	7527	9673	1.33266967524998
R-HSA-1483226	Synthesis of PI	  5	0.725062616235642	1	2	3	7532	9675	0.913830634457128
R-HSA-1483248	Synthesis of PIPs at the ER membrane	  5	0.725062616235642	1	2	3	7532	9675	0.913830634457128
R-HSA-1483249	Inositol phosphate metabolism	 48	0.154681573721289	0.430549981996921	25	23	7509	9655	1.18988363861605
R-HSA-1483255	PI Metabolism	 78	0.0733998944725509	0.280799596292811	41	37	7493	9641	1.20086717989558
R-HSA-1489509	DAG and IP3 signaling	 34	0.286462668728667	0.630397471622333	17	17	7517	9661	1.14228829307141
R-HSA-1500620	Meiosis	 66	0.862678029109658	1	25	41	7509	9637	0.865369918993492
R-HSA-1502540	Signaling by Activin	 12	0.438356178848967	0.788030825997375	6	6	7528	9672	1.14228829307141
R-HSA-1538133	G0 and Early G1	 24	0.794381484794173	1	9	15	7525	9663	0.856716219803557
R-HSA-156580	Phase II - Conjugation of compounds	 65	0.493103207096504	0.836116384670799	29	36	7505	9642	1.01927263074064
R-HSA-156581	Methylation	 12	0.664572059645248	0.97498346054538	5	7	7529	9671	0.951906910892841
R-HSA-156584	Cytosolic sulfonation of small molecules	 17	0.673674387554733	0.984223558924917	7	10	7527	9668	0.940708006058808
R-HSA-156588	Glucuronidation	  6	0.533523591186547	0.869215486173459	3	3	7531	9675	1.14228829307141
R-HSA-156590	Glutathione conjugation	 26	0.47792638167712	0.822314509650338	12	14	7522	9664	1.05441996283515
R-HSA-1566948	Elastic fibre formation	 39	0.999838375285747	1	7	32	7527	9646	0.410052207769224
R-HSA-1566977	Fibronectin matrix formation	  6	0.968418630418888	1	1	5	7533	9673	0.380762764357137
R-HSA-156711	Polo-like kinase mediated events	 11	0.983040291455655	1	2	9	7532	9669	0.415377561116876
R-HSA-156827	L13a-mediated translational silencing of Ceruloplasmin expression	 65	0.394689845286435	0.7272238094254	30	35	7504	9643	1.05441996283515
R-HSA-156842	Eukaryotic Translation Elongation	 48	0.441043986012577	0.791848793301353	22	26	7512	9652	1.04709760198213
R-HSA-156902	Peptide chain elongation	 46	0.454402533202458	0.80364685713825	21	25	7513	9653	1.04295887628259
R-HSA-157579	Telomere Maintenance	 54	0.976529152780758	1	17	37	7517	9641	0.719218554896813
R-HSA-157858	Gap junction trafficking and regulation	 40	0.37384499460542	0.713080369766776	19	21	7515	9657	1.08517387841784
R-HSA-15869	Metabolism of nucleotides	 91	0.526306987904446	0.869215486173459	40	51	7494	9627	1.00420948841443
R-HSA-1592230	Mitochondrial biogenesis	 89	6.71964688401394e-08	2.35859605628889e-05	64	25	7470	9653	1.64284159003529
R-HSA-159227	Transport of the SLBP independent Mature mRNA	 32	0.0550849492524898	0.240514003210775	19	13	7515	9665	1.3564673480223
R-HSA-159230	Transport of the SLBP Dependant Mature mRNA	 33	0.0384037151533486	0.196068422092005	20	13	7514	9665	1.38459187038959
R-HSA-159231	Transport of Mature mRNA Derived from an Intronless Transcript	 38	0.0561324573067647	0.240514003210775	22	16	7512	9662	1.32264960250374
R-HSA-159234	Transport of Mature mRNAs Derived from Intronless Transcripts	 39	0.0402137748256792	0.199505794541532	23	16	7511	9662	1.34731439695602
R-HSA-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript	 64	0.00083908403645754	0.0214195270397525	41	23	7493	9655	1.46355687549774
R-HSA-1592389	Activation of Matrix Metalloproteinases	 27	0.9999588323851	1	3	24	7531	9654	0.253841842904758
R-HSA-159418	Recycling of bile acids and salts	 11	0.335634787499311	0.689943252780429	6	5	7528	9673	1.24613268335063
R-HSA-159740	Gamma-carboxylation of protein precursors	  8	0.92782996623063	1	2	6	7532	9672	0.571144146535705
R-HSA-159763	Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus	  7	0.982247180832935	1	1	6	7533	9672	0.326368083734688
R-HSA-159782	Removal of aminoterminal propeptides from gamma-carboxylated proteins	  8	0.990021068633265	1	1	7	7533	9671	0.285572073267852
R-HSA-159854	Gamma-carboxylation, transport, and amino-terminal cleavage of proteins	  9	0.955061166788585	1	2	7	7532	9671	0.507683685809515
R-HSA-1606322	ZBP1(DAI) mediated induction of type I IFNs	 25	0.83770183604125	1	9	16	7525	9662	0.822447571011415
R-HSA-1606341	IRF3 mediated activation of type 1 IFN	  5	0.725062616235642	1	2	3	7532	9675	0.913830634457128
R-HSA-1614517	Sulfide oxidation to sulfate	  5	0.943820880142438	1	1	4	7533	9674	0.456915317228564
R-HSA-1614558	Degradation of cysteine and homocysteine	  9	0.609856710583998	0.941573171689011	4	5	7530	9673	1.01536737161903
R-HSA-1614635	Sulfur amino acid metabolism	 19	0.290267344867721	0.634790268215391	10	9	7524	9669	1.20240872954885
R-HSA-162588	Budding and maturation of HIV virion	 25	0.263695932235681	0.595558165446897	13	12	7521	9666	1.18797982479427
R-HSA-162592	Integration of provirus	  9	0.349821097790456	0.703404953699137	5	4	7529	9674	1.26920921452379
R-HSA-162594	Early Phase of HIV Life Cycle	 14	0.41673798492329	0.754967910751354	7	7	7527	9671	1.14228829307141
R-HSA-162658	Golgi Cisternae Pericentriolar Stack Reorganization	 13	0.744068200022459	1	5	8	7529	9670	0.878683302362623
R-HSA-162710	Synthesis of glycosylphosphatidylinositol (GPI)	 16	0.397798508650283	0.731032861446332	8	8	7526	9670	1.14228829307141
R-HSA-162791	Attachment of GPI anchor to uPAR	  7	0.030735790599841	0.174004233879745	6	1	7528	9677	1.95820850240813
R-HSA-163125	Post-translational modification: synthesis of GPI-anchored proteins	 75	0.705186257394584	1	31	44	7503	9634	0.944291655605699
R-HSA-163200	Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.	100	1.991522556373e-10	2.7960976691477e-07	75	25	7459	9653	1.71343243960711
R-HSA-163210	Formation of ATP by chemiosmotic coupling	 14	0.00159717071734504	0.0298689098571449	12	2	7522	9676	1.95820850240813
R-HSA-1632852	Macroautophagy	 63	0.00124953839957667	0.0265810895909946	40	23	7494	9655	1.45052481659862
R-HSA-163358	PKA-mediated phosphorylation of key metabolic factors	  5	0.725062616235642	1	2	3	7532	9675	0.913830634457128
R-HSA-163359	Glucagon signaling in metabolic regulation	 29	0.378912596142452	0.713080369766776	14	15	7520	9663	1.10289904158619
R-HSA-163560	Triglyceride catabolism	 21	0.98338664413332	1	5	16	7529	9662	0.543946806224481
R-HSA-163615	PKA activation	 19	0.79847774320632	1	7	12	7527	9666	0.841686110684197
R-HSA-163680	AMPK inhibits chREBP transcriptional activation activity	  7	0.365829538336403	0.703595440855219	4	3	7530	9675	1.30547233493875
R-HSA-163765	ChREBP activates metabolic gene expression	  8	0.237373749552604	0.550864040284059	5	3	7529	9675	1.42786036633926
R-HSA-163767	PP2A-mediated dephosphorylation of key metabolic factors	  7	0.137397306189089	0.406117511346276	5	2	7529	9676	1.63184041867344
R-HSA-1638074	Keratan sulfate/keratin metabolism	 31	0.931711631573888	1	10	21	7524	9657	0.736960189078329
R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	 52	0.635885494714352	0.969362903994517	22	30	7512	9648	0.966551632598885
R-HSA-163841	Gamma carboxylation, hypusine formation and arylsulfatase activation	 35	0.951916150940509	1	11	24	7523	9654	0.718009784216315
R-HSA-1643713	Signaling by EGFR in Cancer	 17	0.00647143831494953	0.0744745851982717	13	4	7521	9674	1.74702915410921
R-HSA-164378	PKA activation in glucagon signalling	 17	0.828321512294211	1	6	11	7528	9667	0.806321148050407
R-HSA-164843	2-LTR circle formation	  7	0.659294130824154	0.97498346054538	3	4	7531	9674	0.979104251204065
R-HSA-164938	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	 18	0.106837625761412	0.342213013964338	11	7	7523	9671	1.39613013597617
R-HSA-164940	Nef mediated downregulation of MHC class I complex cell surface expression	  8	0.494285327120202	0.836116384670799	4	4	7530	9674	1.14228829307141
R-HSA-164944	Nef and signal transduction	  7	0.365829538336403	0.703595440855219	4	3	7530	9675	1.30547233493875
R-HSA-164952	The role of Nef in HIV-1 replication and disease pathogenesis	 24	0.0505154590336138	0.232536736010471	15	9	7519	9669	1.42786036633926
R-HSA-165054	Rev-mediated nuclear export of HIV RNA	 33	0.0170024598485556	0.131886484129128	21	12	7513	9666	1.45382146390907
R-HSA-1650814	Collagen biosynthesis and modifying enzymes	 56	0.499073234529721	0.840166452373775	25	31	7509	9647	1.0199002616709
R-HSA-165159	mTOR signalling	 38	0.00510230009728674	0.0645372012305458	25	13	7509	9665	1.50301091193607
R-HSA-1655829	Regulation of cholesterol biosynthesis by SREBP (SREBF)	 54	3.55652911182345e-07	9.98673374600026e-05	42	12	7492	9666	1.7768929003333
R-HSA-1660499	Synthesis of PIPs at the plasma membrane	 50	0.321016556496641	0.675490234068904	24	26	7510	9652	1.09659676134855
R-HSA-1660514	Synthesis of PIPs at the Golgi membrane	 15	0.156997476800224	0.430549981996921	9	6	7525	9672	1.37074595168569
R-HSA-1660516	Synthesis of PIPs at the early endosome membrane	 16	0.104535729823545	0.340529384390387	10	6	7524	9672	1.42786036633926
R-HSA-1660517	Synthesis of PIPs at the late endosome membrane	 11	0.0514395498033363	0.232971380399626	8	3	7526	9675	1.6615102444675
R-HSA-166058	MyD88:Mal cascade initiated on plasma membrane	 90	0.253447912777352	0.576209041042369	43	47	7491	9631	1.09151992449046
R-HSA-1660661	Sphingolipid de novo biosynthesis	 41	0.310696999760529	0.661844326818712	20	21	7514	9657	1.1144276029965
R-HSA-1660662	Glycosphingolipid metabolism	 39	0.570472959913106	0.901964004186939	17	22	7517	9656	0.995841076010973
R-HSA-166166	MyD88-independent TLR3/TLR4 cascade 	 94	0.0412670833980645	0.201177031565564	50	44	7484	9634	1.2152003117781
R-HSA-166208	mTORC1-mediated signalling	 22	0.108979889132403	0.342213013964338	13	9	7521	9669	1.34997707362985
R-HSA-1663150	The activation of arylsulfatases	 11	0.983040291455655	1	2	9	7532	9669	0.415377561116876
R-HSA-166658	Complement cascade	 46	0.999998591492265	1	6	40	7528	9638	0.297988250366455
R-HSA-166662	Lectin pathway of complement activation	  5	1	1	0	5	7534	9673	0
R-HSA-166663	Initial triggering of complement	 25	1	1	0	25	7534	9653	0
R-HSA-166665	Terminal pathway of complement	  6	0.968418630418888	1	1	5	7533	9673	0.380762764357137
R-HSA-166786	Creation of C4 and C2 activators	 19	1	1	0	19	7534	9659	0
R-HSA-167021	PLC-gamma1 signalling	 36	0.399120519054308	0.731547269911551	17	19	7517	9659	1.07882783234522
R-HSA-167152	Formation of HIV elongation complex in the absence of HIV Tat	 38	0.0125353688536408	0.11415828303327	24	14	7510	9664	1.44289047545862
R-HSA-167158	Formation of the HIV-1 Early Elongation Complex	 27	0.0138723286327914	0.121190695524412	18	9	7516	9669	1.52305105742855
R-HSA-167160	RNA Pol II CTD phosphorylation and interaction with CE during HIV infection	 22	0.00573347924512929	0.0693948694841511	16	6	7518	9672	1.6615102444675
R-HSA-167161	HIV Transcription Initiation	 40	0.0561884565905513	0.240514003210775	23	17	7511	9661	1.31363153703212
R-HSA-167162	RNA Polymerase II HIV Promoter Escape	 40	0.0561884565905513	0.240514003210775	23	17	7511	9661	1.31363153703212
R-HSA-167169	HIV Transcription Elongation	 36	0.0119026230113871	0.111408551386583	23	13	7511	9665	1.45959059670236
R-HSA-167172	Transcription of the HIV genome	 61	0.0222926479135359	0.14903436469765	35	26	7499	9652	1.31082263139342
R-HSA-167200	Formation of HIV-1 elongation complex containing HIV-1 Tat	 36	0.0119026230113871	0.111408551386583	23	13	7511	9665	1.45959059670236
R-HSA-167238	Pausing and recovery of Tat-mediated HIV elongation	 27	0.0770101025065856	0.28566813102332	16	11	7518	9667	1.35382316215871
R-HSA-167242	Abortive elongation of HIV-1 transcript in the absence of Tat	 20	0.108246273291187	0.342213013964338	12	8	7522	9670	1.37074595168569
R-HSA-167243	Tat-mediated HIV elongation arrest and recovery	 27	0.0770101025065856	0.28566813102332	16	11	7518	9667	1.35382316215871
R-HSA-167246	Tat-mediated elongation of the HIV-1 transcript	 36	0.0119026230113871	0.111408551386583	23	13	7511	9665	1.45959059670236
R-HSA-167287	HIV elongation arrest and recovery	 29	0.0775023504194203	0.28566813102332	17	12	7517	9666	1.33923455049751
R-HSA-167290	Pausing and recovery of HIV elongation	 29	0.0775023504194203	0.28566813102332	17	12	7517	9666	1.33923455049751
R-HSA-167590	Nef Mediated CD4 Down-regulation	  9	0.0424092247753092	0.20391284789224	7	2	7527	9676	1.7768929003333
R-HSA-1679131	Trafficking and processing of endosomal TLR	 12	0.846156869006207	1	4	8	7530	9670	0.761525528714273
R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade	 92	0.0643053376150572	0.259438775895231	48	44	7486	9634	1.19195300146582
R-HSA-168142	Toll Like Receptor 10 (TLR10) Cascade	 81	0.0573876942480413	0.242687719048946	43	38	7491	9640	1.21279991610051
R-HSA-168164	Toll Like Receptor 3 (TLR3) Cascade	 94	0.0412670833980645	0.201177031565564	50	44	7484	9634	1.2152003117781
R-HSA-168176	Toll Like Receptor 5 (TLR5) Cascade	 81	0.0573876942480413	0.242687719048946	43	38	7491	9640	1.21279991610051
R-HSA-168179	Toll Like Receptor TLR1:TLR2 Cascade	 91	0.285082527996713	0.628345163747857	43	48	7491	9630	1.07952520004551
R-HSA-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	 88	0.0991621289107556	0.330697456034919	45	43	7489	9635	1.16824939064121
R-HSA-168188	Toll Like Receptor TLR6:TLR2 Cascade	 90	0.253447912777352	0.576209041042369	43	47	7491	9631	1.09151992449046
R-HSA-168253	Host Interactions with Influenza Factors	 39	0.0402137748256792	0.199505794541532	23	16	7511	9662	1.34731439695602
R-HSA-168255	Influenza Life Cycle	 97	0.00385163731224237	0.051997103715272	56	41	7478	9637	1.31893081261853
R-HSA-168271	Transport of Ribonucleoproteins into the Host Nucleus	 30	0.00962468946289896	0.0975093761272612	20	10	7514	9668	1.52305105742855
R-HSA-168273	Influenza Viral RNA Transcription and Replication	 88	0.0161174828989487	0.128974491985449	49	39	7485	9639	1.27209378092043
R-HSA-168274	Export of Viral Ribonucleoproteins from Nucleus	 31	0.0374792572108393	0.192046996802987	19	12	7515	9666	1.40022435924882
R-HSA-168276	 NS1 Mediated Effects on Host Pathways	 37	0.0185756194162323	0.139466147916525	23	14	7511	9664	1.42014220219689
R-HSA-168325	Viral Messenger RNA Synthesis	 40	0.00549923750054375	0.0683268092987914	26	14	7508	9664	1.48497478099283
R-HSA-168333	NEP/NS2 Interacts with the Cellular Export Machinery	 30	0.0243561581720445	0.15614632910297	19	11	7515	9667	1.44689850455712
R-HSA-168638	NOD1/2 Signaling Pathway	 32	0.295689836449504	0.640661312307259	16	16	7518	9662	1.14228829307141
R-HSA-168643	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	 48	0.0958801422917291	0.324375228379729	26	22	7508	9656	1.23747898416069
R-HSA-168799	Neurotoxicity of clostridium toxins	 10	0.00356682631174566	0.0495692091466413	9	1	7525	9677	2.05611892752854
R-HSA-168928	DDX58/IFIH1-mediated induction of interferon-alpha/beta	 67	0.384474244952599	0.713080369766776	31	36	7503	9642	1.05704289806608
R-HSA-169911	Regulation of Apoptosis	 45	0.126538466129544	0.378805983893134	24	21	7510	9657	1.21844084594284
R-HSA-170660	Adenylate cyclase activating pathway	 10	0.972283282592251	1	2	8	7532	9670	0.456915317228564
R-HSA-170670	Adenylate cyclase inhibitory pathway	 13	0.967259494222963	1	3	10	7531	9668	0.527209981417574
R-HSA-170822	Regulation of Glucokinase by Glucokinase Regulatory Protein	 30	0.054356302887927	0.240514003210775	18	12	7516	9666	1.37074595168569
R-HSA-170834	Signaling by TGF-beta Receptor Complex	 69	0.287184118457762	0.630996091259309	33	36	7501	9642	1.092623584677
R-HSA-171007	p38MAPK events	 13	0.744068200022459	1	5	8	7529	9670	0.878683302362623
R-HSA-171306	Packaging Of Telomere Ends	 26	0.997826553210182	1	5	21	7529	9657	0.439341651181311
R-HSA-171319	Telomere Extension By Telomerase	  6	0.82083212876019	1	2	4	7532	9674	0.761525528714273
R-HSA-173623	Classical antibody-mediated complement activation	 14	1	1	0	14	7534	9664	0
R-HSA-173736	Alternative complement activation	  5	1	1	0	5	7534	9673	0
R-HSA-174048	APC/C:Cdc20 mediated degradation of Cyclin B	 20	0.108246273291187	0.342213013964338	12	8	7522	9670	1.37074595168569
R-HSA-174084	Autodegradation of Cdh1 by Cdh1:APC/C	 55	0.0406536482728696	0.200272709386347	31	24	7503	9654	1.28767043946232
R-HSA-174113	SCF-beta-TrCP mediated degradation of Emi1	 46	0.158310555807735	0.431588389037009	24	22	7510	9656	1.19195300146582
R-HSA-174143	APC/C-mediated degradation of cell cycle proteins	 74	0.115419722173435	0.360109533181118	38	36	7496	9642	1.17316094964091
R-HSA-174154	APC/C:Cdc20 mediated degradation of Securin	 57	0.0694012377260447	0.273706004964513	31	26	7503	9652	1.24248902053381
R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	 62	0.0850371734957376	0.307711833989731	33	29	7501	9649	1.21598431197924
R-HSA-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A	 61	0.0674201274244983	0.268159905338421	33	28	7501	9650	1.23591848102808
R-HSA-174362	Transport and synthesis of PAPS	  5	0.384410212719386	0.713080369766776	3	2	7531	9676	1.37074595168569
R-HSA-174403	Glutathione synthesis and recycling	 11	0.335634787499311	0.689943252780429	6	5	7528	9673	1.24613268335063
R-HSA-174411	Polymerase switching on the C-strand of the telomere	 12	0.664572059645248	0.97498346054538	5	7	7529	9671	0.951906910892841
R-HSA-174414	Processive synthesis on the C-strand of the telomere	 10	0.463642417579759	0.80364685713825	5	5	7529	9673	1.14228829307141
R-HSA-174417	Telomere C-strand (Lagging Strand) Synthesis	 22	0.518555392229442	0.867761347664048	10	12	7524	9666	1.03844390279219
R-HSA-174430	Telomere C-strand synthesis initiation	  7	1	1	0	7	7534	9671	0
R-HSA-174437	Removal of the Flap Intermediate from the C-strand	  9	0.609856710583998	0.941573171689011	4	5	7530	9673	1.01536737161903
R-HSA-174490	Membrane binding and targetting of GAG proteins	 13	0.537378235041711	0.869215486173459	6	7	7528	9671	1.05441996283515
R-HSA-174495	Synthesis And Processing Of GAG, GAGPOL Polyproteins	 13	0.537378235041711	0.869215486173459	6	7	7528	9671	1.05441996283515
R-HSA-174577	Activation of C3 and C5	  5	1	1	0	5	7534	9673	0
R-HSA-174824	Plasma lipoprotein assembly, remodeling, and clearance	 57	0.545643180260649	0.875837445272813	25	32	7509	9646	1.00200727462404
R-HSA-175474	Assembly Of The HIV Virion	 15	0.50915074542219	0.854059314901738	7	8	7527	9670	1.06613574019998
R-HSA-176033	Interactions of Vpr with host cellular proteins	 35	0.0178361493969284	0.136841277340369	22	13	7512	9665	1.43601956843263
R-HSA-176187	Activation of ATR in response to replication stress	 27	0.00474417655468293	0.0616742952108781	19	8	7515	9670	1.60766500506347
R-HSA-176407	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	 17	0.0236438152460147	0.152976574218454	12	5	7522	9673	1.61264229610081
R-HSA-176408	Regulation of APC/C activators between G1/S and early anaphase	 68	0.0805342202671132	0.294453242851633	36	32	7498	9646	1.20948172207561
R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	 64	0.128942156909876	0.384680222847623	33	31	7501	9647	1.17798480222989
R-HSA-176412	Phosphorylation of the APC/C	 17	0.157009680044461	0.430549981996921	10	7	7524	9671	1.34386858008401
R-HSA-176417	Phosphorylation of Emi1	  5	0.943820880142438	1	1	4	7533	9674	0.456915317228564
R-HSA-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	 65	0.155293809500665	0.430549981996921	33	32	7501	9646	1.15986195911866
R-HSA-176974	Unwinding of DNA	 11	0.78562859921922	1	4	7	7530	9671	0.830755122233752
R-HSA-177243	Interactions of Rev with host cellular proteins	 35	0.0178361493969284	0.136841277340369	22	13	7512	9665	1.43601956843263
R-HSA-177504	Retrograde neurotrophin signalling	 14	0.0346936751821096	0.182804057271934	10	4	7524	9674	1.63184041867344
R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	 48	0.556664215776438	0.891170534720775	21	27	7513	9651	0.999502256437483
R-HSA-179409	APC-Cdc20 mediated degradation of Nek2A	 21	0.0732464862615547	0.280799596292811	13	8	7521	9670	1.41426169618365
R-HSA-179419	APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint	 62	0.0850371734957376	0.307711833989731	33	29	7501	9649	1.21598431197924
R-HSA-1799339	SRP-dependent cotranslational protein targeting to membrane	 68	0.250708412575679	0.573281125824517	33	35	7501	9643	1.10869157856931
R-HSA-180024	DARPP-32 events	 26	0.0216999285124624	0.148618046982913	17	9	7517	9669	1.49376161401646
R-HSA-180534	Vpu mediated degradation of CD4	 44	0.24686505768845	0.568723018937463	22	22	7512	9656	1.14228829307141
R-HSA-180585	Vif-mediated degradation of APOBEC3G	 46	0.158310555807735	0.431588389037009	24	22	7510	9656	1.19195300146582
R-HSA-180689	APOBEC3G mediated resistance to HIV-1 infection	  5	0.725062616235642	1	2	3	7532	9675	0.913830634457128
R-HSA-180746	Nuclear import of Rev protein	 32	0.0550849492524898	0.240514003210775	19	13	7515	9665	1.3564673480223
R-HSA-180786	Extension of Telomeres	 28	0.610278907576211	0.941573171689011	12	16	7522	9662	0.979104251204065
R-HSA-180910	Vpr-mediated nuclear import of PICs	 32	0.0254332573928681	0.162310424452667	20	12	7514	9666	1.42786036633926
R-HSA-1810476	RIP-mediated NFkB activation via ZBP1	 21	0.883074554727646	1	7	14	7527	9664	0.761525528714273
R-HSA-181429	Serotonin Neurotransmitter Release Cycle	 16	3.88644739393952e-05	0.00341035758818193	15	1	7519	9677	2.14179054950889
R-HSA-181430	Norepinephrine Neurotransmitter Release Cycle	 18	0.00358216774713079	0.0495692091466413	14	4	7520	9674	1.7768929003333
R-HSA-181431	Acetylcholine binding and downstream events	  8	1	1	0	8	7534	9670	0
R-HSA-181438	Toll Like Receptor 2 (TLR2) Cascade	 91	0.285082527996713	0.628345163747857	43	48	7491	9630	1.07952520004551
R-HSA-182218	Nef Mediated CD8 Down-regulation	  6	0.00702553355821219	0.0795471702881445	6	0	7528	9678	2.28457658614282
R-HSA-182971	EGFR downregulation	 23	0.0112181010512623	0.109376485249807	16	7	7518	9671	1.58927066862109
R-HSA-1834941	STING mediated induction of host immune responses	 14	0.41673798492329	0.754967910751354	7	7	7527	9671	1.14228829307141
R-HSA-1834949	Cytosolic sensors of pathogen-associated DNA 	 63	0.1590593349042	0.431952236374269	32	31	7502	9647	1.16041985327889
R-HSA-1839117	Signaling by cytosolic FGFR1 fusion mutants	 17	0.0236438152460147	0.152976574218454	12	5	7522	9673	1.61264229610081
R-HSA-1839122	Signaling by activated point mutants of FGFR1	 10	0.996847475671805	1	1	9	7533	9669	0.228457658614282
R-HSA-1839124	FGFR1 mutant receptor activation	 29	0.525736349992809	0.869215486173459	13	16	7521	9662	1.02412053861575
R-HSA-1839126	FGFR2 mutant receptor activation	 26	0.770053608092921	1	10	16	7524	9662	0.878683302362623
R-HSA-1839130	Signaling by activated point mutants of FGFR3	 10	0.996847475671805	1	1	9	7533	9669	0.228457658614282
R-HSA-1855167	Synthesis of pyrophosphates in the cytosol	 10	0.0883599329364341	0.30936993975749	7	3	7527	9675	1.59920361029997
R-HSA-1855183	Synthesis of IP2, IP, and Ins in the cytosol	 14	0.228922908324908	0.550864040284059	8	6	7526	9672	1.30547233493875
R-HSA-1855204	Synthesis of IP3 and IP4 in the cytosol	 27	0.54583886368498	0.875837445272813	12	15	7522	9663	1.01536737161903
R-HSA-186712	Regulation of beta-cell development	 23	0.975451281462474	1	6	17	7528	9661	0.595976500732909
R-HSA-187015	Activation of TRKA receptors	  5	0.725062616235642	1	2	3	7532	9675	0.913830634457128
R-HSA-187577	SCF(Skp2)-mediated degradation of p27/p21	 52	0.221066926534115	0.550766050641046	26	26	7508	9652	1.14228829307141
R-HSA-189200	Cellular hexose transport	 16	0.991420794489887	1	3	13	7531	9665	0.428358109901779
R-HSA-189445	Metabolism of porphyrins	 15	0.0637194926441077	0.25856117824372	10	5	7524	9673	1.52305105742855
R-HSA-189451	Heme biosynthesis	 11	0.0514395498033363	0.232971380399626	8	3	7526	9675	1.6615102444675
R-HSA-190236	Signaling by FGFR	 75	0.0372743747048331	0.191696784196284	41	34	7493	9644	1.24890186709141
R-HSA-190239	FGFR3 ligand binding and activation	 11	0.99822819409342	1	1	10	7533	9668	0.207688780558438
R-HSA-190241	FGFR2 ligand binding and activation	 14	0.996253727949064	1	2	12	7532	9666	0.326368083734688
R-HSA-190242	FGFR1 ligand binding and activation	 13	0.999440406692629	1	1	12	7533	9666	0.175736660472525
R-HSA-190322	FGFR4 ligand binding and activation	 10	1	1	0	10	7534	9668	0
R-HSA-190371	FGFR3b ligand binding and activation	  6	0.968418630418888	1	1	5	7533	9673	0.380762764357137
R-HSA-190372	FGFR3c ligand binding and activation	 11	0.99822819409342	1	1	10	7533	9668	0.207688780558438
R-HSA-190373	FGFR1c ligand binding and activation	 11	0.99822819409342	1	1	10	7533	9668	0.207688780558438
R-HSA-190375	FGFR2c ligand binding and activation	 11	0.99822819409342	1	1	10	7533	9668	0.207688780558438
R-HSA-190377	FGFR2b ligand binding and activation	  6	0.82083212876019	1	2	4	7532	9674	0.761525528714273
R-HSA-190828	Gap junction trafficking	 38	0.269439993213317	0.603339314946565	19	19	7515	9659	1.14228829307141
R-HSA-190840	Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane	 13	0.537378235041711	0.869215486173459	6	7	7528	9671	1.05441996283515
R-HSA-190861	Gap junction assembly	 27	0.902595853409678	1	9	18	7525	9660	0.761525528714273
R-HSA-190872	Transport of connexons to the plasma membrane	 14	0.627858422630527	0.961301227233654	6	8	7528	9670	0.979104251204065
R-HSA-190873	Gap junction degradation	 12	0.000809142878954761	0.0210377148528238	11	1	7523	9677	2.09419520396425
R-HSA-1912399	Pre-NOTCH Processing in the Endoplasmic Reticulum	  5	0.384410212719386	0.713080369766776	3	2	7531	9676	1.37074595168569
R-HSA-1912408	Pre-NOTCH Transcription and Translation	 29	0.0363562160583976	0.18766223288967	18	11	7516	9667	1.41801305346796
R-HSA-1912420	Pre-NOTCH Processing in Golgi	 18	0.380908722953782	0.713080369766776	9	9	7525	9669	1.14228829307141
R-HSA-1912422	Pre-NOTCH Expression and Processing	 44	0.0292627845524285	0.174004233879745	26	18	7508	9660	1.34997707362985
R-HSA-191273	Cholesterol biosynthesis	 24	0.020089769576217	0.140964159688353	16	8	7518	9670	1.52305105742855
R-HSA-191859	snRNP Assembly	 47	0.0739692863086078	0.281444113759581	26	21	7508	9657	1.26380832424922
R-HSA-192105	Synthesis of bile acids and bile salts	 27	0.393035779167294	0.725181745613057	13	14	7521	9664	1.09998131925395
R-HSA-192823	Viral mRNA Translation	 46	0.454402533202458	0.80364685713825	21	25	7513	9653	1.04295887628259
R-HSA-193048	Androgen biosynthesis	  9	0.349821097790456	0.703404953699137	5	4	7529	9674	1.26920921452379
R-HSA-193368	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	 17	0.673674387554733	0.984223558924917	7	10	7527	9668	0.940708006058808
R-HSA-193634	Axonal growth inhibition (RHOA activation)	  9	0.349821097790456	0.703404953699137	5	4	7529	9674	1.26920921452379
R-HSA-193639	p75NTR signals via NF-kB	 15	0.706996874102752	1	6	9	7528	9669	0.913830634457128
R-HSA-193648	NRAGE signals death through JNK	 51	0.072236790527038	0.279395189807056	28	23	7506	9655	1.25427734141174
R-HSA-193670	p75NTR negatively regulates cell cycle via SC1	  6	0.968418630418888	1	1	5	7533	9673	0.380762764357137
R-HSA-193692	Regulated proteolysis of p75NTR	  9	0.349821097790456	0.703404953699137	5	4	7529	9674	1.26920921452379
R-HSA-193697	p75NTR regulates axonogenesis	 10	0.463642417579759	0.80364685713825	5	5	7529	9673	1.14228829307141
R-HSA-193704	p75 NTR receptor-mediated signalling	 85	0.0350244240784547	0.182804057271934	46	39	7488	9639	1.23635909367729
R-HSA-193775	Synthesis of bile acids and bile salts via 24-hydroxycholesterol	  9	0.99439105636385	1	1	8	7533	9670	0.253841842904758
R-HSA-193807	Synthesis of bile acids and bile salts via 27-hydroxycholesterol	  9	0.609856710583998	0.941573171689011	4	5	7530	9673	1.01536737161903
R-HSA-194002	Glucocorticoid biosynthesis	  5	0.943820880142438	1	1	4	7533	9674	0.456915317228564
R-HSA-194068	Bile acid and bile salt metabolism	 32	0.295689836449504	0.640661312307259	16	16	7518	9662	1.14228829307141
R-HSA-194313	VEGF ligand-receptor interactions	  7	0.885447327934604	1	2	5	7532	9673	0.652736167469377
R-HSA-194441	Metabolism of non-coding RNA	 47	0.0739692863086078	0.281444113759581	26	21	7508	9657	1.26380832424922
R-HSA-195253	Degradation of beta-catenin by the destruction complex	 76	0.0165444780264691	0.129258522166377	43	33	7491	9645	1.29258938426502
R-HSA-195399	VEGF binds to VEGFR leading to receptor dimerization	  7	0.885447327934604	1	2	5	7532	9673	0.652736167469377
R-HSA-196025	Formation of annular gap junctions	 11	0.00170506393454777	0.0299238720513134	10	1	7524	9677	2.07688780558438
R-HSA-196071	Metabolism of steroid hormones	 26	0.633069797307465	0.966119560238783	11	15	7523	9663	0.966551632598885
R-HSA-196108	Pregnenolone biosynthesis	 10	0.463642417579759	0.80364685713825	5	5	7529	9673	1.14228829307141
R-HSA-196299	Beta-catenin phosphorylation cascade	 17	0.00647143831494953	0.0744745851982717	13	4	7521	9674	1.74702915410921
R-HSA-1963640	GRB2 events in ERBB2 signaling	 13	0.0583854648694112	0.244696097542249	9	4	7525	9674	1.58162994425272
R-HSA-1963642	PI3K events in ERBB2 signaling	 13	0.0583854648694112	0.244696097542249	9	4	7525	9674	1.58162994425272
R-HSA-196741	Cobalamin (Cbl, vitamin B12) transport and metabolism	 18	0.380908722953782	0.713080369766776	9	9	7525	9669	1.14228829307141
R-HSA-196757	Metabolism of folate and pterines	 12	0.0958686086119971	0.324375228379729	8	4	7526	9674	1.52305105742855
R-HSA-196780	Biotin transport and metabolism	 11	0.152970603419355	0.430549981996921	7	4	7527	9674	1.45382146390907
R-HSA-196783	Coenzyme A biosynthesis	  8	0.237373749552604	0.550864040284059	5	3	7529	9675	1.42786036633926
R-HSA-196807	Nicotinate metabolism	 29	0.525736349992809	0.869215486173459	13	16	7521	9662	1.02412053861575
R-HSA-196836	Vitamin C (ascorbate) metabolism	  8	0.758299413046526	1	3	5	7531	9673	0.856716219803557
R-HSA-196843	Vitamin B2 (riboflavin) metabolism	  7	0.365829538336403	0.703595440855219	4	3	7530	9675	1.30547233493875
R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	 26	0.47792638167712	0.822314509650338	12	14	7522	9664	1.05441996283515
R-HSA-197264	Nicotinamide salvaging	 17	0.927602542634	1	5	12	7529	9666	0.671934290042006
R-HSA-1980143	Signaling by NOTCH1	 68	0.050042579986601	0.231880469640884	37	31	7497	9647	1.24307843657771
R-HSA-1980145	Signaling by NOTCH2	 29	0.0363562160583976	0.18766223288967	18	11	7516	9667	1.41801305346796
R-HSA-1980148	Signaling by NOTCH3	 10	0.0227160641348271	0.14903436469765	8	2	7526	9676	1.82766126891426
R-HSA-1980150	Signaling by NOTCH4	 10	0.0883599329364341	0.30936993975749	7	3	7527	9675	1.59920361029997
R-HSA-198323	AKT phosphorylates targets in the cytosol	 14	0.228922908324908	0.550864040284059	8	6	7526	9672	1.30547233493875
R-HSA-198693	AKT phosphorylates targets in the nucleus	  9	0.349821097790456	0.703404953699137	5	4	7529	9674	1.26920921452379
R-HSA-198725	Nuclear Events (kinase and transcription factor activation)	 25	0.0126029443519635	0.11415828303327	17	8	7517	9670	1.55351207857712
R-HSA-198753	ERK/MAPK targets	 22	0.0182724669891678	0.137927654047267	15	7	7519	9671	1.55766585418829
R-HSA-198933	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	 99	0.999999999999771	1	11	88	7523	9590	0.253841842904758
R-HSA-199220	Vitamin B5 (pantothenate) metabolism	 15	0.0637194926441077	0.25856117824372	10	5	7524	9673	1.52305105742855
R-HSA-199418	Negative regulation of the PI3K/AKT network	 87	0.710833263517297	1	36	51	7498	9627	0.945342035645304
R-HSA-199920	CREB phosphorylation	  7	0.365829538336403	0.703595440855219	4	3	7530	9675	1.30547233493875
R-HSA-199992	trans-Golgi Network Vesicle Budding	 64	4.81459588852647e-06	0.000675969262749116	46	18	7488	9660	1.64203942129015
R-HSA-200425	Import of palmitoyl-CoA into the mitochondrial matrix	 13	0.891529610776762	1	4	9	7530	9669	0.702946641890098
R-HSA-201451	Signaling by BMP	 28	0.315863056864165	0.667879114212783	14	14	7520	9664	1.14228829307141
R-HSA-201688	WNT mediated activation of DVL	  7	0.982247180832935	1	1	6	7533	9672	0.326368083734688
R-HSA-201722	Formation of the beta-catenin:TCF transactivating complex	 56	0.993431911194261	1	16	40	7518	9638	0.652736167469377
R-HSA-202040	G-protein activation	 22	0.351702476849568	0.703404953699137	11	11	7523	9667	1.14228829307141
R-HSA-202131	Metabolism of nitric oxide	 22	0.351702476849568	0.703404953699137	11	11	7523	9667	1.14228829307141
R-HSA-2022090	Assembly of collagen fibrils and other multimeric structures	 52	0.819052968305236	1	20	32	7514	9646	0.878683302362623
R-HSA-2022377	Metabolism of Angiotensinogen to Angiotensins	 12	0.989691676292018	1	2	10	7532	9668	0.380762764357137
R-HSA-2022854	Keratan sulfate biosynthesis	 25	0.83770183604125	1	9	16	7525	9662	0.822447571011415
R-HSA-2022857	Keratan sulfate degradation	 11	0.983040291455655	1	2	9	7532	9669	0.415377561116876
R-HSA-2022870	Chondroitin sulfate biosynthesis	 18	0.380908722953782	0.713080369766776	9	9	7525	9669	1.14228829307141
R-HSA-2022923	Dermatan sulfate biosynthesis	 11	0.570315442646798	0.901964004186939	5	6	7529	9672	1.03844390279219
R-HSA-2022928	HS-GAG biosynthesis	 28	0.85355624710717	1	10	18	7524	9660	0.815920209336721
R-HSA-202403	TCR signaling	 92	0.0643053376150572	0.259438775895231	48	44	7486	9634	1.19195300146582
R-HSA-2024096	HS-GAG degradation	 22	0.819529001771798	1	8	14	7526	9664	0.830755122233752
R-HSA-2024101	CS/DS degradation	 14	0.41673798492329	0.754967910751354	7	7	7527	9671	1.14228829307141
R-HSA-202424	Downstream TCR signaling	 76	0.0473676116341953	0.223168210518155	41	35	7493	9643	1.23246894778757
R-HSA-202427	Phosphorylation of CD3 and TCR zeta chains	 11	0.983040291455655	1	2	9	7532	9669	0.415377561116876
R-HSA-202430	Translocation of ZAP-70 to Immunological synapse	  9	0.955061166788585	1	2	7	7532	9671	0.507683685809515
R-HSA-202433	Generation of second messenger molecules	 21	0.615976127962565	0.948279039100264	9	12	7525	9666	0.979104251204065
R-HSA-202670	ERKs are inactivated	 13	0.0162648228566036	0.128974491985449	10	3	7524	9675	1.75736660472525
R-HSA-2028269	Signaling by Hippo	 20	0.365643666811852	0.703595440855219	10	10	7524	9668	1.14228829307141
R-HSA-2029480	Fcgamma receptor (FCGR) dependent phagocytosis	 87	0.12045389370303	0.364191974904051	44	43	7490	9635	1.15541804356648
R-HSA-2029481	FCGR activation	 17	0.999204679675961	1	2	15	7532	9663	0.268773716016802
R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation	 63	0.1590593349042	0.431952236374269	32	31	7502	9647	1.16041985327889
R-HSA-2029485	Role of phospholipids in phagocytosis	 29	0.885203327156966	1	10	19	7524	9659	0.78778502970442
R-HSA-2032785	YAP1- and WWTR1 (TAZ)-stimulated gene expression	 25	0.0126029443519635	0.11415828303327	17	8	7517	9670	1.55351207857712
R-HSA-2033514	FGFR3 mutant receptor activation	 10	0.996847475671805	1	1	9	7533	9669	0.228457658614282
R-HSA-2033519	Activated point mutants of FGFR2	 12	0.999004241166275	1	1	11	7533	9667	0.190381382178568
R-HSA-203615	eNOS activation	 12	0.232913396149656	0.550864040284059	7	5	7527	9673	1.33266967524998
R-HSA-203641	NOSTRIN mediated eNOS trafficking	  5	0.943820880142438	1	1	4	7533	9674	0.456915317228564
R-HSA-203765	eNOS activation and regulation	 22	0.351702476849568	0.703404953699137	11	11	7523	9667	1.14228829307141
R-HSA-203927	MicroRNA (miRNA) biogenesis	 21	0.000564849999409163	0.0178886621889475	17	4	7517	9674	1.84941914116323
R-HSA-204005	COPII (Coat Protein 2) Mediated Vesicle Transport	 62	0.0163514669326282	0.128974491985449	36	26	7498	9652	1.32652834034099
R-HSA-204174	Regulation of pyruvate dehydrogenase (PDH) complex	 14	0.0346936751821096	0.182804057271934	10	4	7524	9674	1.63184041867344
R-HSA-2046104	alpha-linolenic (omega3) and linoleic (omega6) acid metabolism	 11	0.152970603419355	0.430549981996921	7	4	7527	9674	1.45382146390907
R-HSA-2046105	Linoleic acid (LA) metabolism	  6	0.533523591186547	0.869215486173459	3	3	7531	9675	1.14228829307141
R-HSA-2046106	alpha-linolenic acid (ALA) metabolism	 11	0.152970603419355	0.430549981996921	7	4	7527	9674	1.45382146390907
R-HSA-204998	Cell death signalling via NRAGE, NRIF and NADE	 65	0.0223135437747158	0.14903436469765	37	28	7497	9650	1.30045128749668
R-HSA-205025	NADE modulates death signalling	  6	0.82083212876019	1	2	4	7532	9674	0.761525528714273
R-HSA-205043	NRIF signals cell death from the nucleus	 13	0.155841638600134	0.430549981996921	8	5	7526	9673	1.4058932837802
R-HSA-209543	p75NTR recruits signalling complexes	 12	0.664572059645248	0.97498346054538	5	7	7529	9671	0.951906910892841
R-HSA-209560	NF-kB is activated and signals survival	 12	0.664572059645248	0.97498346054538	5	7	7529	9671	0.951906910892841
R-HSA-209776	Amine-derived hormones	 10	0.972283282592251	1	2	8	7532	9670	0.456915317228564
R-HSA-209822	Glycoprotein hormones	  8	0.92782996623063	1	2	6	7532	9672	0.571144146535705
R-HSA-209952	Peptide hormone biosynthesis	 10	0.886172703573919	1	3	7	7531	9671	0.685372975842846
R-HSA-209968	Thyroxine biosynthesis	  7	0.885447327934604	1	2	5	7532	9673	0.652736167469377
R-HSA-210500	Glutamate Neurotransmitter Release Cycle	 24	8.16615121821187e-05	0.00419151113715512	20	4	7514	9674	1.90381382178568
R-HSA-210744	Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells	  6	0.968418630418888	1	1	5	7533	9673	0.380762764357137
R-HSA-210745	Regulation of gene expression in beta cells	 15	0.948415029542587	1	4	11	7530	9667	0.609220422971418
R-HSA-210747	Regulation of gene expression in early pancreatic precursor cells	  5	1	1	0	5	7534	9673	0
R-HSA-210990	PECAM1 interactions	 11	0.570315442646798	0.901964004186939	5	6	7529	9672	1.03844390279219
R-HSA-210991	Basigin interactions	 22	0.912729146107042	1	7	15	7527	9663	0.726910731954533
R-HSA-210993	Tie2 Signaling	 16	0.224448294341669	0.550864040284059	9	7	7525	9671	1.28507432970534
R-HSA-211000	Gene Silencing by RNA	 92	0.0263249180776881	0.166729749998129	50	42	7484	9636	1.24161770986023
R-HSA-211227	Activation of DNA fragmentation factor	 12	0.846156869006207	1	4	8	7530	9670	0.761525528714273
R-HSA-211733	Regulation of activated PAK-2p34 by proteasome mediated degradation	 42	0.165873938693459	0.447000019051089	22	20	7512	9658	1.19668297369386
R-HSA-211897	Cytochrome P450 - arranged by substrate type	 44	0.927646977678779	1	15	29	7519	9649	0.778832927094143
R-HSA-211935	Fatty acids	  9	1	1	0	9	7534	9669	0
R-HSA-211945	Phase I - Functionalization of compounds	 80	0.973971914464496	1	27	53	7507	9625	0.771044597823201
R-HSA-211958	Miscellaneous substrates	  9	0.99439105636385	1	1	8	7533	9670	0.253841842904758
R-HSA-211976	Endogenous sterols	 19	0.643495873373604	0.97498346054538	8	11	7526	9667	0.961926983639082
R-HSA-211979	Eicosanoids	  9	1	1	0	9	7534	9669	0
R-HSA-211981	Xenobiotics	 15	0.986483012934125	1	3	12	7531	9666	0.456915317228564
R-HSA-211999	CYP2E1 reactions	  6	0.82083212876019	1	2	4	7532	9674	0.761525528714273
R-HSA-2122947	NOTCH1 Intracellular Domain Regulates Transcription	 45	0.292499659954434	0.63867732904514	22	23	7512	9655	1.11690410878093
R-HSA-2122948	Activated NOTCH1 Transmits Signal to the Nucleus	 27	0.0350068483079032	0.182804057271934	17	10	7517	9668	1.43843710979363
R-HSA-212300	PRC2 methylates histones and DNA	 35	0.951916150940509	1	11	24	7523	9654	0.718009784216315
R-HSA-212676	Dopamine Neurotransmitter Release Cycle	 21	9.23844185634952e-05	0.00419151113715512	18	3	7516	9675	1.95820850240813
R-HSA-212718	EGFR interacts with phospholipase C-gamma	 35	0.227873793899547	0.550864040284059	18	17	7516	9661	1.17492510144488
R-HSA-2129379	Molecules associated with elastic fibres	 32	0.999274866265186	1	6	26	7528	9652	0.428358109901779
R-HSA-2132295	MHC class II antigen presentation	 97	0.0499181834295042	0.231880469640884	51	46	7483	9632	1.20116913292045
R-HSA-2142670	Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)	  6	0.533523591186547	0.869215486173459	3	3	7531	9675	1.14228829307141
R-HSA-2142688	Synthesis of 5-eicosatetraenoic acids	  6	0.82083212876019	1	2	4	7532	9674	0.761525528714273
R-HSA-2142691	Synthesis of Leukotrienes (LT) and Eoxins (EX)	 17	0.994592539329979	1	3	14	7531	9664	0.403160574025203
R-HSA-2142712	Synthesis of 12-eicosatetraenoic acid derivatives	  6	0.82083212876019	1	2	4	7532	9674	0.761525528714273
R-HSA-2142753	Arachidonic acid metabolism	 46	0.989784948148112	1	13	33	7521	9645	0.645641209127318
R-HSA-2142789	Ubiquinol biosynthesis	  7	0.365829538336403	0.703595440855219	4	3	7530	9675	1.30547233493875
R-HSA-2142816	Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)	  7	0.659294130824154	0.97498346054538	3	4	7531	9674	0.979104251204065
R-HSA-2142845	Hyaluronan metabolism	 15	0.948415029542587	1	4	11	7530	9667	0.609220422971418
R-HSA-2151201	Transcriptional activation of mitochondrial biogenesis	 55	0.000365678881431819	0.0125222719397628	37	18	7497	9660	1.53689697613244
R-HSA-2151209	Activation of PPARGC1A (PGC-1alpha) by phosphorylation	 10	0.235999778001153	0.550864040284059	6	4	7528	9674	1.37074595168569
R-HSA-216083	Integrin cell surface interactions	 69	0.996007791590375	1	20	49	7514	9629	0.662196111925455
R-HSA-2160916	Hyaluronan uptake and degradation	 11	0.923876742706931	1	3	8	7531	9670	0.623066341675314
R-HSA-2161522	Abacavir transport and metabolism	  9	0.99439105636385	1	1	8	7533	9670	0.253841842904758
R-HSA-2161541	Abacavir metabolism	  5	0.943820880142438	1	1	4	7533	9674	0.456915317228564
R-HSA-2162123	Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	 12	0.989691676292018	1	2	10	7532	9668	0.380762764357137
R-HSA-2168880	Scavenging of heme from plasma	 18	0.999528662753623	1	2	16	7532	9662	0.253841842904758
R-HSA-2173782	Binding and Uptake of Ligands by Scavenger Receptors	 45	0.99994460083866	1	8	37	7526	9641	0.406146948647612
R-HSA-2173788	Downregulation of TGF-beta receptor signaling	 24	0.497392044456026	0.838341453080745	11	13	7523	9665	1.04709760198213
R-HSA-2173789	TGF-beta receptor signaling activates SMADs	 30	0.443177360892993	0.792638235278678	14	16	7520	9662	1.06613574019998
R-HSA-2173791	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	 13	0.891529610776762	1	4	9	7530	9669	0.702946641890098
R-HSA-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	 42	0.100406013232546	0.333910375111037	23	19	7511	9659	1.25107765431631
R-HSA-2173795	Downregulation of SMAD2/3:SMAD4 transcriptional activity	 22	0.210031976235314	0.534211765641994	12	10	7522	9668	1.24613268335063
R-HSA-2173796	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	 30	0.305467150713263	0.657785091413223	15	15	7519	9663	1.14228829307141
R-HSA-2179392	EGFR Transactivation by Gastrin	  8	0.0151772407427947	0.125346152958139	7	1	7527	9677	1.99900451287497
R-HSA-2187338	Visual phototransduction	 86	0.998249308367626	1	25	61	7509	9617	0.664121100622913
R-HSA-2197563	NOTCH2 intracellular domain regulates transcription	 11	0.335634787499311	0.689943252780429	6	5	7528	9673	1.24613268335063
R-HSA-2214320	Anchoring fibril formation	 13	0.744068200022459	1	5	8	7529	9670	0.878683302362623
R-HSA-2219528	PI3K/AKT Signaling in Cancer	 76	0.65725291061498	0.97498346054538	32	44	7502	9634	0.961926983639082
R-HSA-2219530	Constitutive Signaling by Aberrant PI3K in Cancer	 51	0.914759993470147	1	18	33	7516	9645	0.806321148050407
R-HSA-2243919	Crosslinking of collagen fibrils	 16	0.773740174150865	1	6	10	7528	9668	0.856716219803557
R-HSA-2262749	Cellular response to hypoxia	 64	0.264268331248872	0.595558165446897	31	33	7503	9645	1.10659178391293
R-HSA-2299718	Condensation of Prophase Chromosomes	 38	0.997011595144363	1	9	29	7525	9649	0.541083928296983
R-HSA-2393930	Phosphate bond hydrolysis by NUDT proteins	  7	0.365829538336403	0.703595440855219	4	3	7530	9675	1.30547233493875
R-HSA-2408508	Metabolism of ingested SeMet, Sec, MeSec into H2Se	  6	0.82083212876019	1	2	4	7532	9674	0.761525528714273
R-HSA-2408517	SeMet incorporation into proteins	 10	0.235999778001153	0.550864040284059	6	4	7528	9674	1.37074595168569
R-HSA-2408522	Selenoamino acid metabolism	 71	0.365080435159345	0.703595440855219	33	38	7501	9640	1.06184545553117
R-HSA-2408557	Selenocysteine synthesis	 50	0.321016556496641	0.675490234068904	24	26	7510	9652	1.09659676134855
R-HSA-2426168	Activation of gene expression by SREBF (SREBP)	 41	1.63218404613985e-06	0.000381512112672089	33	8	7501	9670	1.83880554494422
R-HSA-2428933	SHC-related events triggered by IGF1R	  9	0.0424092247753092	0.20391284789224	7	2	7527	9676	1.7768929003333
R-HSA-2453864	Retinoid cycle disease events	  6	0.533523591186547	0.869215486173459	3	3	7531	9675	1.14228829307141
R-HSA-2453902	The canonical retinoid cycle in rods (twilight vision)	 20	0.975626493816955	1	5	15	7529	9663	0.571144146535705
R-HSA-2465910	MASTL Facilitates Mitotic Progression	 10	0.0883599329364341	0.30936993975749	7	3	7527	9675	1.59920361029997
R-HSA-2468052	Establishment of Sister Chromatid Cohesion	 10	0.463642417579759	0.80364685713825	5	5	7529	9673	1.14228829307141
R-HSA-2470946	Cohesin Loading onto Chromatin	 10	0.0883599329364341	0.30936993975749	7	3	7527	9675	1.59920361029997
R-HSA-2474795	Diseases associated with visual transduction	  6	0.533523591186547	0.869215486173459	3	3	7531	9675	1.14228829307141
R-HSA-2485179	Activation of the phototransduction cascade	 10	0.996847475671805	1	1	9	7533	9669	0.228457658614282
R-HSA-2500257	Resolution of Sister Chromatid Cohesion	 97	0.203107923677755	0.526694363207872	47	50	7487	9628	1.10695978916198
R-HSA-2514853	Condensation of Prometaphase Chromosomes	  9	0.832520764277791	1	3	6	7531	9672	0.761525528714273
R-HSA-2514856	The phototransduction cascade	 32	0.813816992323299	1	12	20	7522	9658	0.856716219803557
R-HSA-2514859	Inactivation, recovery and regulation of the phototransduction cascade	 31	0.772000963798325	1	12	19	7522	9659	0.884352226893995
R-HSA-2559580	Oxidative Stress Induced Senescence	 82	0.358565137677038	0.703595440855219	38	44	7496	9634	1.05870622284667
R-HSA-2559582	Senescence-Associated Secretory Phenotype (SASP)	 69	0.970746979248828	1	23	46	7511	9632	0.761525528714273
R-HSA-2559584	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	 14	0.978869416255817	1	3	11	7531	9667	0.489552125602033
R-HSA-2559585	Oncogene Induced Senescence	 30	0.00962468946289896	0.0975093761272612	20	10	7514	9668	1.52305105742855
R-HSA-2559586	DNA Damage/Telomere Stress Induced Senescence	 50	0.998891629319405	1	12	38	7522	9640	0.548298380674277
R-HSA-2562578	TRIF-mediated programmed cell death	  9	0.99439105636385	1	1	8	7533	9670	0.253841842904758
R-HSA-2564830	Cytosolic iron-sulfur cluster assembly	 10	0.463642417579759	0.80364685713825	5	5	7529	9673	1.14228829307141
R-HSA-2565942	Regulation of PLK1 Activity at G2/M Transition	 83	0.00181607989802502	0.0310948314247212	50	33	7484	9645	1.37625095550772
R-HSA-2644602	Signaling by NOTCH1 PEST Domain Mutants in Cancer	 54	0.0301545858005733	0.174004233879745	31	23	7503	9655	1.31151618834125
R-HSA-2644603	Signaling by NOTCH1 in Cancer	 54	0.0301545858005733	0.174004233879745	31	23	7503	9655	1.31151618834125
R-HSA-2644605	FBXW7 Mutants and NOTCH1 in Cancer	  5	0.384410212719386	0.713080369766776	3	2	7531	9676	1.37074595168569
R-HSA-2644606	Constitutive Signaling by NOTCH1 PEST Domain Mutants	 54	0.0301545858005733	0.174004233879745	31	23	7503	9655	1.31151618834125
R-HSA-2644607	Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling	  5	0.384410212719386	0.713080369766776	3	2	7531	9676	1.37074595168569
R-HSA-264642	Acetylcholine Neurotransmitter Release Cycle	 15	0.000799277871872753	0.0210377148528238	13	2	7521	9676	1.97996637465711
R-HSA-264870	Caspase-mediated cleavage of cytoskeletal proteins	 12	0.664572059645248	0.97498346054538	5	7	7529	9671	0.951906910892841
R-HSA-264876	Insulin processing	 28	0.00873644836260046	0.0931803569005018	19	9	7515	9669	1.55024839773977
R-HSA-2660825	Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	  7	0.365829538336403	0.703595440855219	4	3	7530	9675	1.30547233493875
R-HSA-2660826	Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	  7	0.365829538336403	0.703595440855219	4	3	7530	9675	1.30547233493875
R-HSA-2672351	Stimuli-sensing channels	 89	0.0809500964029256	0.295205026882357	46	43	7488	9635	1.18079239283786
R-HSA-2682334	EPH-Ephrin signaling	 90	0.00138586581067114	0.0270243833080872	54	36	7480	9642	1.37074595168569
R-HSA-2691230	Signaling by NOTCH1 HD Domain Mutants in Cancer	 14	0.228922908324908	0.550864040284059	8	6	7526	9672	1.30547233493875
R-HSA-2691232	Constitutive Signaling by NOTCH1 HD Domain Mutants	 14	0.228922908324908	0.550864040284059	8	6	7526	9672	1.30547233493875
R-HSA-2871809	FCERI mediated Ca+2 mobilization	 39	0.931782010011245	1	13	26	7521	9652	0.761525528714273
R-HSA-2871837	FCERI mediated NF-kB activation	 80	0.367407230809172	0.704699114830708	37	43	7497	9635	1.05661667109105
R-HSA-2892245	POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation	  8	0.758299413046526	1	3	5	7531	9673	0.856716219803557
R-HSA-2892247	POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation	  8	0.758299413046526	1	3	5	7531	9673	0.856716219803557
R-HSA-2894858	Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	 54	0.0301545858005733	0.174004233879745	31	23	7503	9655	1.31151618834125
R-HSA-2894862	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	 54	0.0301545858005733	0.174004233879745	31	23	7503	9655	1.31151618834125
R-HSA-2979096	NOTCH2 Activation and Transmission of Signal to the Nucleus	 19	0.0266620186308492	0.167863112814853	13	6	7521	9672	1.56313134841351
R-HSA-2980736	Peptide hormone metabolism	 70	0.079067745913757	0.289846253950169	37	33	7497	9645	1.20756190981835
R-HSA-2980766	Nuclear Envelope Breakdown	 50	0.227122170447465	0.550864040284059	25	25	7509	9653	1.14228829307141
R-HSA-2980767	Activation of NIMA Kinases NEK9, NEK6, NEK7	  7	0.982247180832935	1	1	6	7533	9672	0.326368083734688
R-HSA-2993913	Clearance of Nuclear Envelope Membranes from Chromatin	  8	0.758299413046526	1	3	5	7531	9673	0.856716219803557
R-HSA-2995383	Initiation of Nuclear Envelope Reformation	 12	0.232913396149656	0.550864040284059	7	5	7527	9673	1.33266967524998
R-HSA-2995410	Nuclear Envelope Reassembly	 12	0.232913396149656	0.550864040284059	7	5	7527	9673	1.33266967524998
R-HSA-3000157	Laminin interactions	 27	0.815355104516448	1	10	17	7524	9661	0.846139476349192
R-HSA-3000170	Syndecan interactions	 26	0.939921818256369	1	8	18	7526	9660	0.702946641890098
R-HSA-3000171	Non-integrin membrane-ECM interactions	 55	0.834646531098735	1	21	34	7513	9644	0.87229287834544
R-HSA-3000178	ECM proteoglycans	 61	0.861554061397655	1	23	38	7511	9640	0.861397729201391
R-HSA-3000471	Scavenging by Class B Receptors	  5	1	1	0	5	7534	9673	0
R-HSA-3000480	Scavenging by Class A Receptors	 18	0.984491160706561	1	4	14	7530	9664	0.507683685809515
R-HSA-3000484	Scavenging by Class F Receptors	  6	0.533523591186547	0.869215486173459	3	3	7531	9675	1.14228829307141
R-HSA-3065676	SUMO is conjugated to E1 (UBA2:SAE1)	  5	0.725062616235642	1	2	3	7532	9675	0.913830634457128
R-HSA-3065678	SUMO is transferred from E1 to E2 (UBE2I, UBC9)	  6	0.82083212876019	1	2	4	7532	9674	0.761525528714273
R-HSA-3065679	SUMO is proteolytically processed	  5	0.119239284310492	0.361580896699634	4	1	7530	9677	1.82766126891426
R-HSA-3108214	SUMOylation of DNA damage response and repair proteins	 74	0.0165716054059458	0.129258522166377	42	32	7492	9646	1.2966515759189
R-HSA-3134963	DEx/H-box helicases activate type I IFN and inflammatory cytokines production 	 12	0.846156869006207	1	4	8	7530	9670	0.761525528714273
R-HSA-3134973	LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production	  5	0.384410212719386	0.713080369766776	3	2	7531	9676	1.37074595168569
R-HSA-3134975	Regulation of innate immune responses to cytosolic DNA	 13	0.537378235041711	0.869215486173459	6	7	7528	9671	1.05441996283515
R-HSA-3214815	HDACs deacetylate histones	 53	0.969944178563164	1	17	36	7517	9642	0.732788716309961
R-HSA-3214841	PKMTs methylate histone lysines	 48	0.0148655195732233	0.125346152958139	29	19	7505	9659	1.38026502079462
R-HSA-3214842	HDMs demethylate histones	 30	0.910998285079997	1	10	20	7524	9658	0.761525528714273
R-HSA-3214847	HATs acetylate histones	 98	0.126459348501635	0.378805983893134	49	49	7485	9629	1.14228829307141
R-HSA-3214858	RMTs methylate histone arginines	 43	0.655704966453956	0.97498346054538	18	25	7516	9653	0.956334384896994
R-HSA-3215018	Processing and activation of SUMO	  8	0.494285327120202	0.836116384670799	4	4	7530	9674	1.14228829307141
R-HSA-3229121	Glycogen storage diseases	  8	0.758299413046526	1	3	5	7531	9673	0.856716219803557
R-HSA-3232118	SUMOylation of transcription factors	 18	0.219724747898273	0.549899369071613	10	8	7524	9670	1.26920921452379
R-HSA-3238698	WNT ligand biogenesis and trafficking	 22	0.988774381285425	1	5	17	7529	9661	0.519221951396095
R-HSA-3270619	IRF3-mediated induction of type I IFN	 11	0.335634787499311	0.689943252780429	6	5	7528	9673	1.24613268335063
R-HSA-3295583	TRP channels	 21	0.770035274836919	1	8	13	7526	9665	0.870314889959169
R-HSA-3296469	Defects in cobalamin (B12) metabolism	  9	0.609856710583998	0.941573171689011	4	5	7530	9673	1.01536737161903
R-HSA-3296482	Defects in vitamin and cofactor metabolism	 15	0.156997476800224	0.430549981996921	9	6	7525	9672	1.37074595168569
R-HSA-3299685	Detoxification of Reactive Oxygen Species	 31	0.867500257442825	1	11	20	7523	9658	0.810656207986162
R-HSA-3301854	Nuclear Pore Complex (NPC) Disassembly	 34	0.105741659471608	0.342213013964338	19	15	7515	9663	1.27667515107981
R-HSA-3304349	Loss of Function of SMAD2/3 in Cancer	  6	0.82083212876019	1	2	4	7532	9674	0.761525528714273
R-HSA-3304351	Signaling by TGF-beta Receptor Complex in Cancer	  7	0.659294130824154	0.97498346054538	3	4	7531	9674	0.979104251204065
R-HSA-3304356	SMAD2/3 Phosphorylation Motif Mutants in Cancer	  5	0.725062616235642	1	2	3	7532	9675	0.913830634457128
R-HSA-3315487	SMAD2/3 MH2 Domain Mutants in Cancer	  6	0.82083212876019	1	2	4	7532	9674	0.761525528714273
R-HSA-3322077	Glycogen synthesis	 13	0.537378235041711	0.869215486173459	6	7	7528	9671	1.05441996283515
R-HSA-3323169	Defects in biotin (Btn) metabolism	  6	0.0612105093396261	0.252763397390692	5	1	7529	9677	1.90381382178568
R-HSA-3371378	Regulation by c-FLIP	 11	0.983040291455655	1	2	9	7532	9669	0.415377561116876
R-HSA-3371453	Regulation of HSF1-mediated heat shock response	 73	0.00156518556655243	0.0296962234518867	45	28	7489	9650	1.40830063529352
R-HSA-3371497	HSP90 chaperone cycle for steroid hormone receptors (SHR)	 48	0.154681573721289	0.430549981996921	25	23	7509	9655	1.18988363861605
R-HSA-3371511	HSF1 activation	 24	0.109196175396028	0.342213013964338	14	10	7520	9668	1.33266967524998
R-HSA-3371556	Cellular response to heat stress	 92	0.000697168658833848	0.0191926430784848	56	36	7478	9642	1.39061183504346
R-HSA-3371568	Attenuation phase	 21	0.615976127962565	0.948279039100264	9	12	7525	9666	0.979104251204065
R-HSA-3371571	HSF1-dependent transactivation	 31	0.64803347474018	0.97498346054538	13	18	7521	9660	0.958048245801827
R-HSA-3371599	Defective HLCS causes multiple carboxylase deficiency	  6	0.0612105093396261	0.252763397390692	5	1	7529	9677	1.90381382178568
R-HSA-349425	Autodegradation of the E3 ubiquitin ligase COP1	 44	0.162040447511283	0.438352193267518	23	21	7511	9657	1.19421048821102
R-HSA-350054	Notch-HLH transcription pathway	 13	0.155841638600134	0.430549981996921	8	5	7526	9673	1.4058932837802
R-HSA-350562	Regulation of ornithine decarboxylase (ODC)	 44	0.351144952763975	0.703404953699137	21	23	7513	9655	1.0903660979318
R-HSA-351202	Metabolism of polyamines	 69	0.469210992205623	0.812296218318983	31	38	7503	9640	1.02640397348446
R-HSA-351906	Apoptotic cleavage of cell adhesion  proteins	  8	0.92782996623063	1	2	6	7532	9672	0.571144146535705
R-HSA-352230	Amino acid transport across the plasma membrane	 28	0.925825140605602	1	9	19	7525	9659	0.734328188403049
R-HSA-354192	Integrin alphaIIb beta3 signaling	 24	0.893317200610644	1	8	16	7526	9662	0.761525528714273
R-HSA-354194	GRB2:SOS provides linkage to MAPK signaling for Integrins 	 12	0.846156869006207	1	4	8	7530	9670	0.761525528714273
R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	 24	0.794381484794173	1	9	15	7525	9663	0.856716219803557
R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	 19	0.643495873373604	0.97498346054538	8	11	7526	9667	0.961926983639082
R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	 19	0.643495873373604	0.97498346054538	8	11	7526	9667	0.961926983639082
R-HSA-3595172	Defective CHST3 causes SEDCJD	  7	0.365829538336403	0.703595440855219	4	3	7530	9675	1.30547233493875
R-HSA-3595174	Defective CHST14 causes EDS, musculocontractural type	  7	0.365829538336403	0.703595440855219	4	3	7530	9675	1.30547233493875
R-HSA-3595177	Defective CHSY1 causes TPBS	  7	0.365829538336403	0.703595440855219	4	3	7530	9675	1.30547233493875
R-HSA-3656225	Defective CHST6 causes MCDC1	  5	0.943820880142438	1	1	4	7533	9674	0.456915317228564
R-HSA-3656237	Defective EXT2 causes exostoses 2	 12	0.846156869006207	1	4	8	7530	9670	0.761525528714273
R-HSA-3656243	Defective ST3GAL3 causes MCT12 and EIEE15	  5	0.943820880142438	1	1	4	7533	9674	0.456915317228564
R-HSA-3656244	Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)	  5	0.943820880142438	1	1	4	7533	9674	0.456915317228564
R-HSA-3656253	Defective EXT1 causes exostoses 1, TRPS2 and CHDS	 12	0.846156869006207	1	4	8	7530	9670	0.761525528714273
R-HSA-3656532	TGFBR1 KD Mutants in Cancer	  6	0.533523591186547	0.869215486173459	3	3	7531	9675	1.14228829307141
R-HSA-3656534	Loss of Function of TGFBR1 in Cancer	  6	0.533523591186547	0.869215486173459	3	3	7531	9675	1.14228829307141
R-HSA-372708	p130Cas linkage to MAPK signaling for integrins	 12	0.846156869006207	1	4	8	7530	9670	0.761525528714273
R-HSA-373080	Class B/2 (Secretin family receptors)	 73	0.962230560349848	1	25	48	7509	9630	0.782389241829733
R-HSA-373752	Netrin-1 signaling	 47	0.00177273025594941	0.0307273244364564	31	16	7503	9662	1.50684838660484
R-HSA-373753	Nephrin family interactions	 21	0.770035274836919	1	8	13	7526	9665	0.870314889959169
R-HSA-373755	Semaphorin interactions	 62	0.194023853929583	0.511168265773474	31	31	7503	9647	1.14228829307141
R-HSA-375170	CDO in myogenesis	 27	0.54583886368498	0.875837445272813	12	15	7522	9663	1.01536737161903
R-HSA-375280	Amine ligand-binding receptors	 31	0.999957521476252	1	4	27	7530	9651	0.294784075631332
R-HSA-375281	Hormone ligand-binding receptors	  5	0.943820880142438	1	1	4	7533	9674	0.456915317228564
R-HSA-376172	DSCAM interactions	 11	0.0514395498033363	0.232971380399626	8	3	7526	9675	1.6615102444675
R-HSA-376176	Signaling by Robo receptor	 31	0.00608093186529243	0.0729711823835092	21	10	7513	9668	1.54761639706449
R-HSA-3769402	Deactivation of the beta-catenin transactivating complex	 40	0.0284064013472954	0.173402554311316	24	16	7510	9662	1.37074595168569
R-HSA-3772470	Negative regulation of TCF-dependent signaling by WNT ligand antagonists	 12	0.94978336727384	1	3	9	7531	9669	0.571144146535705
R-HSA-3781865	Diseases of glycosylation	 68	0.979754481038442	1	22	46	7512	9632	0.739127719046206
R-HSA-3785653	Myoclonic epilepsy of Lafora	  8	0.758299413046526	1	3	5	7531	9673	0.856716219803557
R-HSA-379716	Cytosolic tRNA aminoacylation	 23	0.0112181010512623	0.109376485249807	16	7	7518	9671	1.58927066862109
R-HSA-379724	tRNA Aminoacylation	 40	0.0284064013472954	0.173402554311316	24	16	7510	9662	1.37074595168569
R-HSA-379726	Mitochondrial tRNA aminoacylation	 20	0.711346076027641	1	8	12	7526	9666	0.913830634457128
R-HSA-380108	Chemokine receptors bind chemokines	 33	0.999524118860043	1	6	27	7528	9651	0.415377561116876
R-HSA-380259	Loss of Nlp from mitotic centrosomes	 67	0.00138304838425564	0.0270243833080872	42	25	7492	9653	1.43212263608953
R-HSA-380270	Recruitment of mitotic centrosome proteins and complexes	 76	8.73096994382578e-05	0.00419151113715512	50	26	7484	9652	1.50301091193607
R-HSA-380284	Loss of proteins required for interphase microtubule organization from the centrosome	 67	0.00138304838425564	0.0270243833080872	42	25	7492	9653	1.43212263608953
R-HSA-380287	Centrosome maturation	 76	8.73096994382578e-05	0.00419151113715512	50	26	7484	9652	1.50301091193607
R-HSA-380320	Recruitment of NuMA to mitotic centrosomes	 85	0.000903905167305396	0.0226621938374424	52	33	7482	9645	1.39762332328737
R-HSA-380972	Energy dependent regulation of mTOR by LKB1-AMPK	 28	0.000186611941429746	0.00748580473621038	22	6	7512	9672	1.79502446054079
R-HSA-380994	ATF4 activates genes	 24	0.020089769576217	0.140964159688353	16	8	7518	9670	1.52305105742855
R-HSA-381033	ATF6 (ATF6-alpha) activates chaperones	 10	0.0227160641348271	0.14903436469765	8	2	7526	9676	1.82766126891426
R-HSA-381038	XBP1(S) activates chaperone genes	 51	0.119188871497498	0.361580896699634	27	24	7507	9654	1.20948172207561
R-HSA-381042	PERK regulates gene expression	 27	0.0770101025065856	0.28566813102332	16	11	7518	9667	1.35382316215871
R-HSA-381070	IRE1alpha activates chaperones	 53	0.179808622511866	0.478127473497462	27	26	7507	9652	1.16384090237464
R-HSA-381119	Unfolded Protein Response (UPR)	 88	0.0161174828989487	0.128974491985449	49	39	7485	9639	1.27209378092043
R-HSA-381183	ATF6 (ATF6-alpha) activates chaperone genes	  8	0.0774114401709801	0.28566813102332	6	2	7528	9676	1.71343243960711
R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	 80	0.215304642555737	0.544662555222081	39	41	7495	9637	1.11373108574462
R-HSA-381676	Glucagon-like Peptide-1 (GLP1) regulates insulin secretion	 38	0.0561324573067647	0.240514003210775	22	16	7512	9662	1.32264960250374
R-HSA-381753	Olfactory Signaling Pathway	 46	0.995810171069502	1	12	34	7522	9644	0.595976500732909
R-HSA-381771	Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)	 14	0.0346936751821096	0.182804057271934	10	4	7524	9674	1.63184041867344
R-HSA-382556	ABC-family proteins mediated transport	 89	0.117788071248309	0.361580896699634	45	44	7489	9634	1.15512299299356
R-HSA-383280	Nuclear Receptor transcription pathway	 46	0.860631791790047	1	17	29	7517	9649	0.844300042704955
R-HSA-388841	Costimulation by the CD28 family	 58	0.382262049412314	0.713080369766776	27	31	7507	9647	1.06350979010097
R-HSA-388844	Receptor-type tyrosine-protein phosphatases	 19	0.290267344867721	0.634790268215391	10	9	7524	9669	1.20240872954885
R-HSA-389356	CD28 co-stimulation	 33	0.627195755440045	0.961301227233654	14	19	7520	9659	0.969214309272711
R-HSA-389357	CD28 dependent PI3K/Akt signaling	 20	0.711346076027641	1	8	12	7526	9666	0.913830634457128
R-HSA-389359	CD28 dependent Vav1 pathway	 13	0.537378235041711	0.869215486173459	6	7	7528	9671	1.05441996283515
R-HSA-389513	CTLA4 inhibitory signaling	 21	0.0292671977501021	0.174004233879745	14	7	7520	9671	1.52305105742855
R-HSA-389599	Alpha-oxidation of phytanate	  6	0.533523591186547	0.869215486173459	3	3	7531	9675	1.14228829307141
R-HSA-389661	Glyoxylate metabolism and glycine degradation	 24	0.497392044456026	0.838341453080745	11	13	7523	9665	1.04709760198213
R-HSA-389887	Beta-oxidation of pristanoyl-CoA	  7	0.365829538336403	0.703595440855219	4	3	7530	9675	1.30547233493875
R-HSA-389948	PD-1 signaling	 14	0.978869416255817	1	3	11	7531	9667	0.489552125602033
R-HSA-389957	Prefoldin mediated transfer of substrate  to CCT/TriC	 24	0.0505154590336138	0.232536736010471	15	9	7519	9669	1.42786036633926
R-HSA-389958	Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding	 27	0.149013553025479	0.429599647736698	15	12	7519	9666	1.26920921452379
R-HSA-389960	Formation of tubulin folding intermediates by CCT/TriC	 21	0.154912655997362	0.430549981996921	12	9	7522	9669	1.30547233493875
R-HSA-389977	Post-chaperonin tubulin folding pathway	 18	0.219724747898273	0.549899369071613	10	8	7524	9670	1.26920921452379
R-HSA-390247	Beta-oxidation of very long chain fatty acids	 10	0.707332905920157	1	4	6	7530	9672	0.913830634457128
R-HSA-390450	Folding of actin by CCT/TriC	 10	0.0227160641348271	0.14903436469765	8	2	7526	9676	1.82766126891426
R-HSA-390466	Chaperonin-mediated protein folding	 80	0.0720352728005021	0.27938542268482	42	38	7492	9640	1.19940270772498
R-HSA-390471	Association of TriC/CCT with target proteins during biosynthesis	 35	0.139233096345996	0.410679132919704	19	16	7515	9662	1.24019871819182
R-HSA-390522	Striated Muscle Contraction	 26	0.873515603778601	1	9	17	7525	9661	0.790814972126361
R-HSA-390666	Serotonin receptors	  9	0.99439105636385	1	1	8	7533	9670	0.253841842904758
R-HSA-390696	Adrenoceptors	  9	1	1	0	9	7534	9669	0
R-HSA-3906995	Diseases associated with O-glycosylation of proteins	 44	0.981778907652139	1	13	31	7521	9647	0.674988536814924
R-HSA-390918	Peroxisomal lipid metabolism	 26	0.633069797307465	0.966119560238783	11	15	7523	9663	0.966551632598885
R-HSA-391160	Signal regulatory protein family interactions	 13	0.322830446624098	0.675490234068904	7	6	7527	9672	1.23015662330767
R-HSA-391251	Protein folding	 86	0.0272565874768856	0.169328534590917	47	39	7487	9639	1.24854766917108
R-HSA-391903	Eicosanoid ligand-binding receptors	 12	0.94978336727384	1	3	9	7531	9669	0.571144146535705
R-HSA-391908	Prostanoid ligand receptors	  9	0.955061166788585	1	2	7	7532	9671	0.507683685809515
R-HSA-392154	Nitric oxide stimulates guanylate cyclase	 23	0.590726165937853	0.925646804661546	10	13	7524	9665	0.993294167888182
R-HSA-392170	ADP signalling through P2Y purinoceptor 12	 18	0.219724747898273	0.549899369071613	10	8	7524	9670	1.26920921452379
R-HSA-392451	G beta:gamma signalling through PI3Kgamma	 40	0.623709632018561	0.959132884287031	17	23	7517	9655	0.970945049110698
R-HSA-392517	Rap1 signalling	 15	0.50915074542219	0.854059314901738	7	8	7527	9670	1.06613574019998
R-HSA-392518	Signal amplification	 28	0.315863056864165	0.667879114212783	14	14	7520	9664	1.14228829307141
R-HSA-392851	Prostacyclin signalling through prostacyclin receptor	 16	0.104535729823545	0.340529384390387	10	6	7524	9672	1.42786036633926
R-HSA-3928662	EPHB-mediated forward signaling	 40	0.00549923750054375	0.0683268092987914	26	14	7508	9664	1.48497478099283
R-HSA-3928663	EPHA-mediated growth cone collapse	 32	0.813816992323299	1	12	20	7522	9658	0.856716219803557
R-HSA-3928664	Ephrin signaling	 19	0.462485963231236	0.80364685713825	9	10	7525	9668	1.08216785659397
R-HSA-3928665	EPH-ephrin mediated repulsion of cells	 47	0.0100285448997822	0.0998587024063419	29	18	7505	9660	1.40963236166259
R-HSA-397795	G-protein beta:gamma signalling	 43	0.655704966453956	0.97498346054538	18	25	7516	9653	0.956334384896994
R-HSA-399719	Trafficking of AMPA receptors	 30	5.51958427718266e-05	0.00387474816258222	24	6	7510	9672	1.82766126891426
R-HSA-399721	Glutamate binding, activation of AMPA receptors and synaptic plasticity	 30	5.51958427718266e-05	0.00387474816258222	24	6	7510	9672	1.82766126891426
R-HSA-399954	Sema3A PAK dependent Axon repulsion	 15	0.0637194926441077	0.25856117824372	10	5	7524	9673	1.52305105742855
R-HSA-399955	SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion	 13	0.537378235041711	0.869215486173459	6	7	7528	9671	1.05441996283515
R-HSA-399956	CRMPs in Sema3A signaling	 15	0.311123401495976	0.661844326818712	8	7	7526	9671	1.21844084594284
R-HSA-399997	Acetylcholine regulates insulin secretion	 10	0.235999778001153	0.550864040284059	6	4	7528	9674	1.37074595168569
R-HSA-400042	Adrenaline,noradrenaline inhibits insulin secretion	 25	0.0761891259550332	0.28566813102332	15	10	7519	9668	1.37074595168569
R-HSA-400253	Circadian Clock	 66	0.082018801588752	0.29832745448344	35	31	7499	9647	1.21151788659089
R-HSA-400451	Free fatty acids regulate insulin secretion	  7	0.659294130824154	0.97498346054538	3	4	7531	9674	0.979104251204065
R-HSA-400508	Incretin synthesis, secretion, and inactivation	 14	0.0346936751821096	0.182804057271934	10	4	7524	9674	1.63184041867344
R-HSA-400511	Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)	  8	0.0151772407427947	0.125346152958139	7	1	7527	9677	1.99900451287497
R-HSA-400685	Sema4D in semaphorin signaling	 26	0.633069797307465	0.966119560238783	11	15	7523	9663	0.966551632598885
R-HSA-4085001	Sialic acid metabolism	 30	0.588869694598551	0.925646804661546	13	17	7521	9661	0.989983187328555
R-HSA-4086398	Ca2+ pathway	 59	0.0115713007484604	0.111274700348208	35	24	7499	9654	1.35525729686438
R-HSA-4086400	PCP/CE pathway	 83	0.0564157925685017	0.240753108711783	44	39	7490	9639	1.2111008408468
R-HSA-416482	G alpha (12/13) signalling events	 76	0.163252930402361	0.440782912086374	38	38	7496	9640	1.14228829307141
R-HSA-416550	Sema4D mediated inhibition of cell attachment and migration	  8	0.237373749552604	0.550864040284059	5	3	7529	9675	1.42786036633926
R-HSA-416572	Sema4D induced cell migration and growth-cone collapse	 23	0.590726165937853	0.925646804661546	10	13	7524	9665	0.993294167888182
R-HSA-416700	Other semaphorin interactions	 16	0.397798508650283	0.731032861446332	8	8	7526	9670	1.14228829307141
R-HSA-416993	Trafficking of GluR2-containing AMPA receptors	 16	0.000396585766565308	0.0132572956251832	14	2	7520	9676	1.99900451287497
R-HSA-417957	P2Y receptors	  9	0.955061166788585	1	2	7	7532	9671	0.507683685809515
R-HSA-418038	Nucleotide-like (purinergic) receptors	 12	0.94978336727384	1	3	9	7531	9669	0.571144146535705
R-HSA-418217	G beta:gamma signalling through PLC beta	 17	0.157009680044461	0.430549981996921	10	7	7524	9671	1.34386858008401
R-HSA-418346	Platelet homeostasis	 82	0.152019374823726	0.430549981996921	41	41	7493	9637	1.14228829307141
R-HSA-418359	Reduction of cytosolic Ca++ levels	 14	0.627858422630527	0.961301227233654	6	8	7528	9670	0.979104251204065
R-HSA-418360	Platelet calcium homeostasis	 27	0.693041064172923	1	11	16	7523	9662	0.930753423984112
R-HSA-418457	cGMP effects	 17	0.828321512294211	1	6	11	7528	9667	0.806321148050407
R-HSA-418592	ADP signalling through P2Y purinoceptor 1	 22	0.210031976235314	0.534211765641994	12	10	7522	9668	1.24613268335063
R-HSA-418597	G alpha (z) signalling events	 42	0.605951742743643	0.941573171689011	18	24	7516	9654	0.979104251204065
R-HSA-418885	DCC mediated attractive signaling	 14	0.0346936751821096	0.182804057271934	10	4	7524	9674	1.63184041867344
R-HSA-418886	Netrin mediated repulsion signals	 10	0.235999778001153	0.550864040284059	6	4	7528	9674	1.37074595168569
R-HSA-418889	Ligand-independent caspase activation via DCC	 10	0.463642417579759	0.80364685713825	5	5	7529	9673	1.14228829307141
R-HSA-418890	Role of second messengers in netrin-1 signaling	  7	0.365829538336403	0.703595440855219	4	3	7530	9675	1.30547233493875
R-HSA-418990	Adherens junctions interactions	 30	0.833613411310906	1	11	19	7523	9659	0.8376780815857
R-HSA-419037	NCAM1 interactions	 38	0.386129059987532	0.714262450886028	18	20	7516	9658	1.08216785659397
R-HSA-419408	Lysosphingolipid and LPA receptors	 13	0.891529610776762	1	4	9	7530	9669	0.702946641890098
R-HSA-419812	Calcitonin-like ligand receptors	  8	0.990021068633265	1	1	7	7533	9671	0.285572073267852
R-HSA-420029	Tight junction interactions	 21	0.99919332001662	1	3	18	7531	9660	0.326368083734688
R-HSA-420092	Glucagon-type ligand receptors	 25	0.408250030362142	0.746332086755791	12	13	7522	9665	1.09659676134855
R-HSA-420499	Class C/3 (Metabotropic glutamate/pheromone receptors)	 18	0.567281174366292	0.901964004186939	8	10	7526	9668	1.01536737161903
R-HSA-420597	Nectin/Necl  trans heterodimerization	  7	0.659294130824154	0.97498346054538	3	4	7531	9674	0.979104251204065
R-HSA-421270	Cell-cell junction organization	 53	0.997088409801729	1	14	39	7520	9639	0.603473060490556
R-HSA-421837	Clathrin derived vesicle budding	 64	4.81459588852647e-06	0.000675969262749116	46	18	7488	9660	1.64203942129015
R-HSA-422085	Synthesis, secretion, and deacylation of Ghrelin	 15	0.0201807664511104	0.140964159688353	11	4	7523	9674	1.6753561631714
R-HSA-422356	Regulation of insulin secretion	 74	0.00904427576442456	0.093988480653562	43	31	7491	9647	1.3275242324884
R-HSA-425366	Transport of bile salts and organic acids, metal ions and amine compounds	 71	0.730534467902296	1	29	42	7505	9636	0.933136915466785
R-HSA-425381	Bicarbonate transporters	  7	0.659294130824154	0.97498346054538	3	4	7531	9674	0.979104251204065
R-HSA-425393	Transport of inorganic cations/anions and amino acids/oligopeptides	 93	0.810770883065324	1	37	56	7497	9622	0.908917566529939
R-HSA-425397	Transport of vitamins, nucleosides, and related molecules	 31	0.365738410202936	0.703595440855219	15	16	7519	9662	1.10544028361749
R-HSA-425410	Metal ion SLC transporters	 24	0.338864063261441	0.694547656670165	12	12	7522	9666	1.14228829307141
R-HSA-425561	Sodium/Calcium exchangers	 12	0.846156869006207	1	4	8	7530	9670	0.761525528714273
R-HSA-425986	Sodium/Proton exchangers	  8	0.758299413046526	1	3	5	7531	9673	0.856716219803557
R-HSA-426048	Arachidonate production from DAG	  5	0.384410212719386	0.713080369766776	3	2	7531	9676	1.37074595168569
R-HSA-426117	Cation-coupled Chloride cotransporters	  6	0.533523591186547	0.869215486173459	3	3	7531	9675	1.14228829307141
R-HSA-426486	Small interfering RNA (siRNA) biogenesis	  9	0.00739667387636194	0.0824200803366045	8	1	7526	9677	2.03073474323806
R-HSA-426496	Post-transcriptional silencing by small RNAs	  7	0.00307382405127406	0.0459781929124406	7	0	7527	9678	2.28457658614282
R-HSA-427359	SIRT1 negatively regulates rRNA Expression	 32	0.997278418056685	1	7	25	7527	9653	0.499751128218742
R-HSA-427389	ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression	 40	0.988855384279736	1	11	29	7523	9649	0.628258561189275
R-HSA-427413	NoRC negatively regulates rRNA expression	 67	0.672296896946875	0.984223558924917	28	39	7506	9639	0.954748424059686
R-HSA-427601	Multifunctional anion exchangers	  8	0.758299413046526	1	3	5	7531	9673	0.856716219803557
R-HSA-428157	Sphingolipid metabolism	 80	0.367407230809172	0.704699114830708	37	43	7497	9635	1.05661667109105
R-HSA-428540	Activation of Rac	 14	0.0346936751821096	0.182804057271934	10	4	7524	9674	1.63184041867344
R-HSA-428543	Inactivation of Cdc42 and Rac	  8	0.0151772407427947	0.125346152958139	7	1	7527	9677	1.99900451287497
R-HSA-428643	Organic anion transporters	  9	0.832520764277791	1	3	6	7531	9672	0.761525528714273
R-HSA-428890	Role of Abl in Robo-Slit signaling	  9	0.0424092247753092	0.20391284789224	7	2	7527	9676	1.7768929003333
R-HSA-428930	Thromboxane signalling through TP receptor	 20	0.108246273291187	0.342213013964338	12	8	7522	9670	1.37074595168569
R-HSA-429914	Deadenylation-dependent mRNA decay	 54	0.00146008358513291	0.0280816075825562	35	19	7499	9659	1.48074408361109
R-HSA-429947	Deadenylation of mRNA	 24	0.109196175396028	0.342213013964338	14	10	7520	9668	1.33266967524998
R-HSA-429958	mRNA decay by 3' to 5' exoribonuclease	 16	0.0115221374123216	0.111274700348208	12	4	7522	9674	1.71343243960711
R-HSA-430039	mRNA decay by 5' to 3' exoribonuclease	 14	0.101030686306554	0.333910375111037	9	5	7525	9673	1.4686563768061
R-HSA-430116	GP1b-IX-V activation signalling	  9	0.609856710583998	0.941573171689011	4	5	7530	9673	1.01536737161903
R-HSA-432040	Vasopressin regulates renal water homeostasis via Aquaporins	 39	0.570472959913106	0.901964004186939	17	22	7517	9656	0.995841076010973
R-HSA-432047	Passive transport by Aquaporins	  9	0.99439105636385	1	1	8	7533	9670	0.253841842904758
R-HSA-432142	Platelet sensitization by LDL	 16	0.0392297503364459	0.196365632397414	11	5	7523	9673	1.57064640297319
R-HSA-432720	Lysosome Vesicle Biogenesis	 30	0.00332671231746293	0.0476602458542648	21	9	7513	9669	1.59920361029997
R-HSA-432722	Golgi Associated Vesicle Biogenesis	 49	0.000255228154195609	0.00924250445115889	34	15	7500	9663	1.58521640671134
R-HSA-433692	Proton-coupled monocarboxylate transport	  5	0.725062616235642	1	2	3	7532	9675	0.913830634457128
R-HSA-434316	Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion	  7	0.659294130824154	0.97498346054538	3	4	7531	9674	0.979104251204065
R-HSA-435354	Zinc transporters	 15	0.311123401495976	0.661844326818712	8	7	7526	9671	1.21844084594284
R-HSA-435368	Zinc efflux and compartmentalization by the SLC30 family	  7	0.365829538336403	0.703595440855219	4	3	7530	9675	1.30547233493875
R-HSA-437239	Recycling pathway of L1	 41	0.0405582192445756	0.200272709386347	24	17	7510	9661	1.3373131235958
R-HSA-438064	Post NMDA receptor activation events	 36	0.0119026230113871	0.111408551386583	23	13	7511	9665	1.45959059670236
R-HSA-438066	Unblocking of NMDA receptor, glutamate binding and activation	 16	0.104535729823545	0.340529384390387	10	6	7524	9672	1.42786036633926
R-HSA-4411364	Binding of TCF/LEF:CTNNB1 to target gene promoters	  8	0.494285327120202	0.836116384670799	4	4	7530	9674	1.14228829307141
R-HSA-4419969	Depolymerisation of the Nuclear Lamina	 14	0.80862918746242	1	5	9	7529	9669	0.815920209336721
R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	 19	0.643495873373604	0.97498346054538	8	11	7526	9667	0.961926983639082
R-HSA-442380	Zinc influx into cells by the SLC39 gene family	  8	0.494285327120202	0.836116384670799	4	4	7530	9674	1.14228829307141
R-HSA-442660	Na+/Cl- dependent neurotransmitter transporters	 15	0.50915074542219	0.854059314901738	7	8	7527	9670	1.06613574019998
R-HSA-442717	CREB phosphorylation through the activation of CaMKK	  6	0.0612105093396261	0.252763397390692	5	1	7529	9677	1.90381382178568
R-HSA-442720	CREB phosphorylation through the activation of Adenylate Cyclase	  7	0.659294130824154	0.97498346054538	3	4	7531	9674	0.979104251204065
R-HSA-442729	CREB phosphorylation through the activation of CaMKII	 16	0.0392297503364459	0.196365632397414	11	5	7523	9673	1.57064640297319
R-HSA-442742	CREB phosphorylation through the activation of Ras	 28	0.00873644836260046	0.0931803569005018	19	9	7515	9669	1.55024839773977
R-HSA-442755	Activation of NMDA receptor and postsynaptic events	 40	0.0131084674833369	0.117976207350032	25	15	7509	9663	1.42786036633926
R-HSA-442982	Ras activation uopn Ca2+ infux through NMDA receptor	 18	0.0139835417912783	0.121190695524412	13	5	7521	9673	1.64997197888093
R-HSA-444257	RSK activation	  6	0.533523591186547	0.869215486173459	3	3	7531	9675	1.14228829307141
R-HSA-444473	Formyl peptide receptors bind formyl peptides and many other ligands	  6	0.82083212876019	1	2	4	7532	9674	0.761525528714273
R-HSA-445095	Interaction between L1 and Ankyrins	 28	0.108513968927974	0.342213013964338	16	12	7518	9666	1.30547233493875
R-HSA-445144	Signal transduction by L1	 19	0.462485963231236	0.80364685713825	9	10	7525	9668	1.08216785659397
R-HSA-445355	Smooth Muscle Contraction	 35	0.607368646358049	0.941573171689011	15	20	7519	9658	0.979104251204065
R-HSA-445717	Aquaporin-mediated transport	 44	0.701967950150988	1	18	26	7516	9652	0.934599512512972
R-HSA-445989	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	 30	0.443177360892993	0.792638235278678	14	16	7520	9662	1.06613574019998
R-HSA-446107	Type I hemidesmosome assembly	  9	0.955061166788585	1	2	7	7532	9671	0.507683685809515
R-HSA-446193	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	 71	0.45780613613057	0.80364685713825	32	39	7502	9639	1.02966832051507
R-HSA-446199	Synthesis of Dolichyl-phosphate	  6	0.235296834252223	0.550864040284059	4	2	7530	9676	1.52305105742855
R-HSA-446210	Synthesis of UDP-N-acetyl-glucosamine	  8	0.758299413046526	1	3	5	7531	9673	0.856716219803557
R-HSA-446219	Synthesis of substrates in N-glycan biosythesis	 59	0.328480701986992	0.685270290623681	28	31	7506	9647	1.08420583749151
R-HSA-446353	Cell-extracellular matrix interactions	 18	0.741379159583741	1	7	11	7527	9667	0.888446450166652
R-HSA-446388	Regulation of cytoskeletal remodeling and cell spreading by IPP complex components	  8	0.758299413046526	1	3	5	7531	9673	0.856716219803557
R-HSA-446652	Interleukin-1 family signaling	 83	0.240434666462598	0.556128948457146	40	43	7494	9635	1.10100076440618
R-HSA-446728	Cell junction organization	 78	0.99930564926584	1	21	57	7513	9621	0.615078311653836
R-HSA-447038	NrCAM interactions	  7	0.030735790599841	0.174004233879745	6	1	7528	9677	1.95820850240813
R-HSA-447041	CHL1 interactions	  6	0.82083212876019	1	2	4	7532	9674	0.761525528714273
R-HSA-447043	Neurofascin interactions	  7	0.030735790599841	0.174004233879745	6	1	7528	9677	1.95820850240813
R-HSA-447115	Interleukin-12 family signaling	 42	0.0561314636066155	0.240514003210775	24	18	7510	9660	1.30547233493875
R-HSA-448706	Interleukin-1 processing	  5	1	1	0	5	7534	9673	0
R-HSA-449836	Other interleukin signaling	 29	0.991612986691128	1	7	22	7527	9656	0.551449520793094
R-HSA-450282	MAPK targets/ Nuclear events mediated by MAP kinases	 31	0.0160678850949108	0.128974491985449	20	11	7514	9667	1.47392037815666
R-HSA-450294	MAP kinase activation in TLR cascade	 60	0.00823987875251975	0.0896805408413777	36	24	7498	9654	1.37074595168569
R-HSA-450302	activated TAK1 mediates p38 MAPK activation	 20	0.365643666811852	0.703595440855219	10	10	7524	9668	1.14228829307141
R-HSA-450321	JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	 19	0.156236410625769	0.430549981996921	11	8	7523	9670	1.32264960250374
R-HSA-450341	Activation of the AP-1 family of transcription factors	 10	0.235999778001153	0.550864040284059	6	4	7528	9674	1.37074595168569
R-HSA-450385	Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA	 17	0.0678039646689028	0.268159905338421	11	6	7523	9672	1.47825543809241
R-HSA-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA	 45	0.199156155319466	0.520698774801731	23	22	7511	9656	1.16767247736189
R-HSA-450513	Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA	 17	0.0678039646689028	0.268159905338421	11	6	7523	9672	1.47825543809241
R-HSA-450520	HuR (ELAVL1) binds and stabilizes mRNA	  7	0.137397306189089	0.406117511346276	5	2	7529	9676	1.63184041867344
R-HSA-450531	Regulation of mRNA stability by proteins that bind AU-rich elements	 76	0.00910429727128521	0.093988480653562	44	32	7490	9646	1.32264960250374
R-HSA-450604	KSRP (KHSRP) binds and destabilizes mRNA	 17	0.00647143831494953	0.0744745851982717	13	4	7521	9674	1.74702915410921
R-HSA-451306	Ionotropic activity of kainate receptors	 12	0.0958686086119971	0.324375228379729	8	4	7526	9674	1.52305105742855
R-HSA-451308	Activation of Ca-permeable Kainate Receptor	 12	0.0958686086119971	0.324375228379729	8	4	7526	9674	1.52305105742855
R-HSA-451326	Activation of kainate receptors upon glutamate binding	 29	0.0363562160583976	0.18766223288967	18	11	7516	9667	1.41801305346796
R-HSA-452723	Transcriptional regulation of pluripotent stem cells	 33	0.489335951862564	0.836116384670799	15	18	7519	9660	1.03844390279219
R-HSA-453276	Regulation of mitotic cell cycle	 74	0.115419722173435	0.360109533181118	38	36	7496	9642	1.17316094964091
R-HSA-4551638	SUMOylation of chromatin organization proteins	 58	0.0881096862776118	0.30936993975749	31	27	7503	9651	1.22106679604185
R-HSA-456926	Thrombin signalling through proteinase activated receptors (PARs)	 27	0.149013553025479	0.429599647736698	15	12	7519	9666	1.26920921452379
R-HSA-4570464	SUMOylation of RNA binding proteins	 44	0.0989258139437467	0.330697456034919	24	20	7510	9658	1.24613268335063
R-HSA-4608870	Asymmetric localization of PCP proteins	 56	0.294692781965262	0.640661312307259	27	29	7507	9649	1.10149228260457
R-HSA-4615885	SUMOylation of DNA replication proteins	 43	0.129048707237344	0.384680222847623	23	20	7511	9658	1.22198282514616
R-HSA-4641257	Degradation of AXIN	 47	0.194054619414004	0.511168265773474	24	23	7510	9655	1.16659229930697
R-HSA-4641258	Degradation of DVL	 49	0.275947251193037	0.614968159801625	24	25	7510	9653	1.11897628709036
R-HSA-4641262	Disassembly of the destruction complex and recruitment of AXIN to the membrane	 29	0.146682114784655	0.429045185745117	16	13	7518	9665	1.26045604752707
R-HSA-4641263	Regulation of FZD by ubiquitination	 19	0.462485963231236	0.80364685713825	9	10	7525	9668	1.08216785659397
R-HSA-4641265	Repression of WNT target genes	 14	0.627858422630527	0.961301227233654	6	8	7528	9670	0.979104251204065
R-HSA-4791275	Signaling by WNT in cancer	 32	0.0550849492524898	0.240514003210775	19	13	7515	9665	1.3564673480223
R-HSA-4839735	AXIN mutants destabilize the destruction complex, activating WNT signaling	 14	0.0346936751821096	0.182804057271934	10	4	7524	9674	1.63184041867344
R-HSA-4839743	phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex	 15	0.0201807664511104	0.140964159688353	11	4	7523	9674	1.6753561631714
R-HSA-4839744	truncated APC mutants destabilize the destruction complex	 14	0.0346936751821096	0.182804057271934	10	4	7524	9674	1.63184041867344
R-HSA-4839748	AMER1 mutants destabilize the destruction complex	 14	0.0346936751821096	0.182804057271934	10	4	7524	9674	1.63184041867344
R-HSA-499943	Interconversion of nucleotide di- and triphosphates	 28	0.459918805163339	0.80364685713825	13	15	7521	9663	1.06069627213774
R-HSA-500657	Presynaptic function of Kainate receptors	 18	0.219724747898273	0.549899369071613	10	8	7524	9670	1.26920921452379
R-HSA-5083625	Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)	 10	1	1	0	10	7534	9668	0
R-HSA-5083632	Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)	 10	1	1	0	10	7534	9668	0
R-HSA-5083635	Defective B3GALTL causes Peters-plus syndrome (PpS)	 29	0.793426795012556	1	11	18	7523	9660	0.866563532674863
R-HSA-5083636	Defective GALNT12 causes colorectal cancer 1 (CRCS1)	 10	1	1	0	10	7534	9668	0
R-HSA-5099900	WNT5A-dependent internalization of FZD4	 15	0.00478874209923416	0.0616825129112364	12	3	7522	9675	1.82766126891426
R-HSA-5140745	WNT5A-dependent internalization of FZD2, FZD5 and ROR2	 12	0.0292250203990059	0.174004233879745	9	3	7525	9675	1.71343243960711
R-HSA-5173105	O-linked glycosylation	 95	0.971233607453352	1	33	62	7501	9616	0.793589761502242
R-HSA-5173214	O-glycosylation of TSR domain-containing proteins	 31	0.772000963798325	1	12	19	7522	9659	0.884352226893995
R-HSA-5205647	Mitophagy	 24	0.00191406502336542	0.0319922296762507	18	6	7516	9672	1.71343243960711
R-HSA-5205685	Pink/Parkin Mediated Mitophagy	 18	0.000694134499470153	0.0191926430784848	15	3	7519	9675	1.90381382178568
R-HSA-5210891	Uptake and function of anthrax toxins	 13	0.155841638600134	0.430549981996921	8	5	7526	9673	1.4058932837802
R-HSA-5213460	RIPK1-mediated regulated necrosis	 19	0.905630355777043	1	6	13	7528	9665	0.721445237729311
R-HSA-5218859	Regulated Necrosis	 19	0.905630355777043	1	6	13	7528	9665	0.721445237729311
R-HSA-5218900	CASP8 activity is inhibited	 11	0.983040291455655	1	2	9	7532	9669	0.415377561116876
R-HSA-5218920	VEGFR2 mediated vascular permeability	 29	0.378912596142452	0.713080369766776	14	15	7520	9663	1.10289904158619
R-HSA-5223345	Miscellaneous transport and binding events	 22	0.0182724669891678	0.137927654047267	15	7	7519	9671	1.55766585418829
R-HSA-5250913	Positive epigenetic regulation of rRNA expression	 69	0.743371750345614	1	28	41	7506	9637	0.927074556695637
R-HSA-5250924	B-WICH complex positively regulates rRNA expression	 54	0.872589336111454	1	20	34	7514	9644	0.846139476349192
R-HSA-5250941	Negative epigenetic regulation of rRNA expression	 70	0.695863828142818	1	29	41	7505	9637	0.946467442830597
R-HSA-5250955	Toxicity of botulinum toxin type D (BoNT/D)	  5	0.119239284310492	0.361580896699634	4	1	7530	9677	1.82766126891426
R-HSA-5250981	Toxicity of botulinum toxin type F (BoNT/F)	  5	0.119239284310492	0.361580896699634	4	1	7530	9677	1.82766126891426
R-HSA-525793	Myogenesis	 27	0.54583886368498	0.875837445272813	12	15	7522	9663	1.01536737161903
R-HSA-5260271	Diseases of Immune System	 22	0.965068337816164	1	6	16	7528	9662	0.623066341675314
R-HSA-532668	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	 32	1.58476662810909e-05	0.00171154795835782	26	6	7508	9672	1.85621847624104
R-HSA-5334118	DNA methylation	 28	0.99907831631399	1	5	23	7529	9655	0.407960104668361
R-HSA-5336415	Uptake and function of diphtheria toxin	  6	0.235296834252223	0.550864040284059	4	2	7530	9676	1.52305105742855
R-HSA-5339562	Uptake and actions of bacterial toxins	 29	0.00169527851628367	0.0299238720513134	21	8	7513	9670	1.65434856237928
R-HSA-5339716	Misspliced GSK3beta mutants stabilize beta-catenin	 15	0.0201807664511104	0.140964159688353	11	4	7523	9674	1.6753561631714
R-HSA-5339717	Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling	  5	0.943820880142438	1	1	4	7533	9674	0.456915317228564
R-HSA-5340588	RNF mutants show enhanced WNT signaling and proliferation	  7	0.885447327934604	1	2	5	7532	9673	0.652736167469377
R-HSA-5357769	Caspase activation via extrinsic apoptotic signalling pathway	 26	0.939921818256369	1	8	18	7526	9660	0.702946641890098
R-HSA-5357786	TNFR1-induced proapoptotic signaling	 13	0.891529610776762	1	4	9	7530	9669	0.702946641890098
R-HSA-5357905	Regulation of TNFR1 signaling	 29	0.248309979066001	0.568723018937463	15	14	7519	9664	1.18167754455663
R-HSA-5357956	TNFR1-induced NFkappaB signaling pathway	 26	0.200430910643358	0.523057618110176	14	12	7520	9666	1.23015662330767
R-HSA-5358346	Hedgehog ligand biogenesis	 57	0.337743543907982	0.69326306381112	27	30	7507	9648	1.08216785659397
R-HSA-5358493	Synthesis of diphthamide-EEF2	  8	0.92782996623063	1	2	6	7532	9672	0.571144146535705
R-HSA-5358508	Mismatch Repair	 13	0.744068200022459	1	5	8	7529	9670	0.878683302362623
R-HSA-5358565	Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)	 12	0.664572059645248	0.97498346054538	5	7	7529	9671	0.951906910892841
R-HSA-5358606	Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)	 12	0.664572059645248	0.97498346054538	5	7	7529	9671	0.951906910892841
R-HSA-5358747	S33 mutants of beta-catenin aren't phosphorylated	 15	0.0201807664511104	0.140964159688353	11	4	7523	9674	1.6753561631714
R-HSA-5358749	S37 mutants of beta-catenin aren't phosphorylated	 15	0.0201807664511104	0.140964159688353	11	4	7523	9674	1.6753561631714
R-HSA-5358751	S45 mutants of beta-catenin aren't phosphorylated	 15	0.0201807664511104	0.140964159688353	11	4	7523	9674	1.6753561631714
R-HSA-5358752	T41 mutants of beta-catenin aren't phosphorylated	 15	0.0201807664511104	0.140964159688353	11	4	7523	9674	1.6753561631714
R-HSA-5362517	Signaling by Retinoic Acid	 36	0.399120519054308	0.731547269911551	17	19	7517	9659	1.07882783234522
R-HSA-5362768	Hh mutants that don't undergo autocatalytic processing are degraded by ERAD	 48	0.0958801422917291	0.324375228379729	26	22	7508	9656	1.23747898416069
R-HSA-5362798	Release of Hh-Np from the secreting cell	  8	0.990021068633265	1	1	7	7533	9671	0.285572073267852
R-HSA-5365859	RA biosynthesis pathway	 18	0.567281174366292	0.901964004186939	8	10	7526	9668	1.01536737161903
R-HSA-5368286	Mitochondrial translation initiation	 75	0.000743281136592501	0.0200685906879975	47	28	7487	9650	1.43166799398283
R-HSA-5368287	Mitochondrial translation	 80	0.000102344026838847	0.00435427314187096	52	28	7482	9650	1.48497478099283
R-HSA-5368598	Negative regulation of TCF-dependent signaling by DVL-interacting proteins	  5	1	1	0	5	7534	9673	0
R-HSA-5387390	Hh mutants abrogate ligand secretion	 50	0.151150688752813	0.430549981996921	26	24	7508	9654	1.18797982479427
R-HSA-5389840	Mitochondrial translation elongation	 74	7.99887524355132e-05	0.00419151113715512	49	25	7485	9653	1.51276017190538
R-HSA-539107	Activation of E2F1 target genes at G1/S	 22	0.68342125270088	0.995356264307091	9	13	7525	9665	0.934599512512972
R-HSA-5419276	Mitochondrial translation termination	 75	5.18232115339159e-05	0.00387474816258222	50	25	7484	9653	1.52305105742855
R-HSA-5423646	Aflatoxin activation and detoxification	 16	0.965085959525821	1	4	12	7530	9666	0.571144146535705
R-HSA-5467337	APC truncation mutants have impaired AXIN binding	 14	0.0346936751821096	0.182804057271934	10	4	7524	9674	1.63184041867344
R-HSA-5467340	AXIN missense mutants destabilize the destruction complex	 14	0.0346936751821096	0.182804057271934	10	4	7524	9674	1.63184041867344
R-HSA-5467348	Truncations of AMER1 destabilize the destruction complex	 14	0.0346936751821096	0.182804057271934	10	4	7524	9674	1.63184041867344
R-HSA-549127	Organic cation transport	  8	0.92782996623063	1	2	6	7532	9672	0.571144146535705
R-HSA-549132	Organic cation/anion/zwitterion transport	 12	0.989691676292018	1	2	10	7532	9668	0.380762764357137
R-HSA-5576886	Phase 4 - resting membrane potential	 16	0.991420794489887	1	3	13	7531	9665	0.428358109901779
R-HSA-5576890	Phase 3 - rapid repolarisation	  5	0.725062616235642	1	2	3	7532	9675	0.913830634457128
R-HSA-5576892	Phase 0 - rapid depolarisation	 40	0.101843231330355	0.334866268823929	22	18	7512	9660	1.25651712237855
R-HSA-5576893	Phase 2 - plateau phase	 21	0.280867226542441	0.621004072544232	11	10	7523	9668	1.19668297369386
R-HSA-5576894	Phase 1 - inactivation of fast Na+ channels	  7	0.365829538336403	0.703595440855219	4	3	7530	9675	1.30547233493875
R-HSA-5578749	Transcriptional regulation by small RNAs	 67	0.294838256497942	0.640661312307259	32	35	7502	9643	1.09114105606821
R-HSA-5578768	Physiological factors	  8	0.758299413046526	1	3	5	7531	9673	0.856716219803557
R-HSA-5578775	Ion homeostasis	 53	0.260797145222207	0.590579341761257	26	27	7508	9651	1.12073568376818
R-HSA-5579029	Metabolic disorders of biological oxidation enzymes	  5	0.943820880142438	1	1	4	7533	9674	0.456915317228564
R-HSA-5601884	PIWI-interacting RNA (piRNA) biogenesis	 23	0.0314994031227408	0.177611092306539	15	8	7519	9670	1.48994125183227
R-HSA-5602358	Diseases associated with the TLR signaling cascade	 22	0.965068337816164	1	6	16	7528	9662	0.623066341675314
R-HSA-5602498	MyD88 deficiency (TLR2/4)	 10	0.996847475671805	1	1	9	7533	9669	0.228457658614282
R-HSA-5603027	IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)	  7	0.659294130824154	0.97498346054538	3	4	7531	9674	0.979104251204065
R-HSA-5603029	IkBA variant leads to EDA-ID	  6	0.533523591186547	0.869215486173459	3	3	7531	9675	1.14228829307141
R-HSA-5603041	IRAK4 deficiency (TLR2/4)	 10	0.996847475671805	1	1	9	7533	9669	0.228457658614282
R-HSA-5607761	Dectin-1 mediated noncanonical NF-kB signaling	 54	0.303095077272891	0.654685366909445	26	28	7508	9650	1.09998131925395
R-HSA-5607763	CLEC7A (Dectin-1) induces NFAT activation	 13	0.0583854648694112	0.244696097542249	9	4	7525	9674	1.58162994425272
R-HSA-5607764	CLEC7A (Dectin-1) signaling	 91	0.161329081682909	0.437270329503482	45	46	7489	9632	1.12973567446623
R-HSA-5610780	Degradation of GLI1 by the proteasome	 52	0.0927757609742867	0.320830464058864	28	24	7506	9654	1.23015662330767
R-HSA-5610783	Degradation of GLI2 by the proteasome	 52	0.0927757609742867	0.320830464058864	28	24	7506	9654	1.23015662330767
R-HSA-5610785	GLI3 is processed to GLI3R by the proteasome	 52	0.147715030862565	0.429382822631557	27	25	7507	9653	1.18622245818954
R-HSA-5610787	Hedgehog 'off' state	100	0.0393010987917902	0.196365632397414	53	47	7481	9631	1.21082559065569
R-HSA-5617472	Activation of anterior HOX genes in hindbrain development during early embryogenesis	 75	0.843721512766199	1	29	46	7505	9632	0.883369613308557
R-HSA-5619084	ABC transporter disorders	 57	0.171098724023094	0.458215557827077	29	28	7505	9650	1.16232843856389
R-HSA-5619102	SLC transporter disorders	  5	0.943820880142438	1	1	4	7533	9674	0.456915317228564
R-HSA-5619115	Disorders of transmembrane transporters	 62	0.271436261228376	0.606841577650701	30	32	7504	9646	1.10544028361749
R-HSA-5619507	Activation of HOX genes during differentiation	 75	0.843721512766199	1	29	46	7505	9632	0.883369613308557
R-HSA-5620912	Anchoring of the basal body to the plasma membrane	 93	0.00200127001680623	0.0326718965534413	55	38	7479	9640	1.35109367997694
R-HSA-5620916	VxPx cargo-targeting to cilium	 20	0.0162378373591587	0.128974491985449	14	6	7520	9672	1.59920361029997
R-HSA-5620920	Cargo trafficking to the periciliary membrane	 46	0.00272208172355989	0.0424644748875343	30	16	7504	9662	1.48994125183227
R-HSA-5620922	BBSome-mediated cargo-targeting to cilium	 20	0.108246273291187	0.342213013964338	12	8	7522	9670	1.37074595168569
R-HSA-5620924	Intraflagellar transport	 47	0.000654866224564023	0.0187639220262834	32	15	7502	9663	1.55545639907596
R-HSA-5621480	Dectin-2 family	 18	0.999528662753623	1	2	16	7532	9662	0.253841842904758
R-HSA-5621575	CD209 (DC-SIGN) signaling	 21	0.280867226542441	0.621004072544232	11	10	7523	9668	1.19668297369386
R-HSA-5625740	RHO GTPases activate PKNs	 57	0.978242508905428	1	18	39	7516	9639	0.721445237729311
R-HSA-5625886	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	 31	0.999754753653329	1	5	26	7529	9652	0.368480094539164
R-HSA-5625900	RHO GTPases activate CIT	 18	0.380908722953782	0.713080369766776	9	9	7525	9669	1.14228829307141
R-HSA-5625970	RHO GTPases activate KTN1	 11	0.570315442646798	0.901964004186939	5	6	7529	9672	1.03844390279219
R-HSA-5626467	RHO GTPases activate IQGAPs	 25	0.033399681086001	0.182804057271934	16	9	7518	9669	1.4621290151314
R-HSA-5626978	TNFR1-mediated ceramide production	  5	0.384410212719386	0.713080369766776	3	2	7531	9676	1.37074595168569
R-HSA-5627117	RHO GTPases Activate ROCKs	 18	0.741379159583741	1	7	11	7527	9667	0.888446450166652
R-HSA-5627123	RHO GTPases activate PAKs	 23	0.153198260231187	0.430549981996921	13	10	7521	9668	1.29128241825464
R-HSA-5628897	TP53 Regulates Metabolic Genes	 80	1.29481400592773e-08	7.81289076439273e-06	60	20	7474	9658	1.71343243960711
R-HSA-5632681	Ligand-receptor interactions	  7	0.885447327934604	1	2	5	7532	9673	0.652736167469377
R-HSA-5632684	Hedgehog 'on' state	 76	0.385932719744819	0.714262450886028	35	41	7499	9637	1.05210763835525
R-HSA-5633008	TP53 Regulates Transcription of Cell Death Genes	 42	0.937477920223713	1	14	28	7520	9650	0.761525528714273
R-HSA-5635838	Activation of SMO	 16	0.991420794489887	1	3	13	7531	9665	0.428358109901779
R-HSA-5635851	GLI proteins bind promoters of Hh responsive genes to promote transcription	  7	0.659294130824154	0.97498346054538	3	4	7531	9674	0.979104251204065
R-HSA-5637810	Constitutive Signaling by EGFRvIII	 14	0.00889328192640117	0.0931803569005018	11	3	7523	9675	1.79502446054079
R-HSA-5637812	Signaling by EGFRvIII in Cancer	 14	0.00889328192640117	0.0931803569005018	11	3	7523	9675	1.79502446054079
R-HSA-5637815	Signaling by Ligand-Responsive EGFR Variants in Cancer	 17	0.00647143831494953	0.0744745851982717	13	4	7521	9674	1.74702915410921
R-HSA-5649702	APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway	  7	0.030735790599841	0.174004233879745	6	1	7528	9677	1.95820850240813
R-HSA-5651801	PCNA-Dependent Long Patch Base Excision Repair	 20	0.214891022923591	0.544597466037403	11	9	7523	9669	1.25651712237855
R-HSA-5652084	Fructose metabolism	  7	0.982247180832935	1	1	6	7533	9672	0.326368083734688
R-HSA-5654219	Phospholipase C-mediated cascade: FGFR1	 13	0.993770254850028	1	2	11	7532	9667	0.351473320945049
R-HSA-5654221	Phospholipase C-mediated cascade; FGFR2	 13	0.993770254850028	1	2	11	7532	9667	0.351473320945049
R-HSA-5654227	Phospholipase C-mediated cascade; FGFR3	 11	0.983040291455655	1	2	9	7532	9669	0.415377561116876
R-HSA-5654228	Phospholipase C-mediated cascade; FGFR4	 11	0.99822819409342	1	1	10	7533	9668	0.207688780558438
R-HSA-5654687	Downstream signaling of activated FGFR1	 28	0.459918805163339	0.80364685713825	13	15	7521	9663	1.06069627213774
R-HSA-5654688	SHC-mediated cascade:FGFR1	 18	0.949067871089597	1	5	13	7529	9665	0.634604607261894
R-HSA-5654689	PI-3K cascade:FGFR1	 18	0.871792688649446	1	6	12	7528	9666	0.761525528714273
R-HSA-5654693	FRS-mediated FGFR1 signaling	 20	0.711346076027641	1	8	12	7526	9666	0.913830634457128
R-HSA-5654695	PI-3K cascade:FGFR2	 18	0.871792688649446	1	6	12	7528	9666	0.761525528714273
R-HSA-5654696	Downstream signaling of activated FGFR2	 25	0.567432198386935	0.901964004186939	11	14	7523	9664	1.00521369790284
R-HSA-5654699	SHC-mediated cascade:FGFR2	 18	0.949067871089597	1	5	13	7529	9665	0.634604607261894
R-HSA-5654700	FRS-mediated FGFR2 signaling	 20	0.711346076027641	1	8	12	7526	9666	0.913830634457128
R-HSA-5654704	SHC-mediated cascade:FGFR3	 16	0.898402239592885	1	5	11	7529	9667	0.713930183169631
R-HSA-5654706	FRS-mediated FGFR3 signaling	 18	0.567281174366292	0.901964004186939	8	10	7526	9668	1.01536737161903
R-HSA-5654708	Downstream signaling of activated FGFR3	 23	0.424733386408509	0.768460920770033	11	12	7523	9666	1.092623584677
R-HSA-5654710	PI-3K cascade:FGFR3	 16	0.773740174150865	1	6	10	7528	9668	0.856716219803557
R-HSA-5654712	FRS-mediated FGFR4 signaling	 18	0.741379159583741	1	7	11	7527	9667	0.888446450166652
R-HSA-5654716	Downstream signaling of activated FGFR4	 23	0.590726165937853	0.925646804661546	10	13	7524	9665	0.993294167888182
R-HSA-5654719	SHC-mediated cascade:FGFR4	 16	0.965085959525821	1	4	12	7530	9666	0.571144146535705
R-HSA-5654720	PI-3K cascade:FGFR4	 16	0.898402239592885	1	5	11	7529	9667	0.713930183169631
R-HSA-5654726	Negative regulation of FGFR1 signaling	 29	0.525736349992809	0.869215486173459	13	16	7521	9662	1.02412053861575
R-HSA-5654727	Negative regulation of FGFR2 signaling	 28	0.459918805163339	0.80364685713825	13	15	7521	9663	1.06069627213774
R-HSA-5654732	Negative regulation of FGFR3 signaling	 26	0.326960953828003	0.683114849962078	13	13	7521	9665	1.14228829307141
R-HSA-5654733	Negative regulation of FGFR4 signaling	 26	0.47792638167712	0.822314509650338	12	14	7522	9664	1.05441996283515
R-HSA-5654736	Signaling by FGFR1	 46	0.240001754831196	0.556043669608911	23	23	7511	9655	1.14228829307141
R-HSA-5654738	Signaling by FGFR2	 63	0.0223168719707479	0.14903436469765	36	27	7498	9651	1.30547233493875
R-HSA-5654741	Signaling by FGFR3	 37	0.136683539047275	0.406117511346276	20	17	7514	9661	1.2349062627799
R-HSA-5654743	Signaling by FGFR4	 36	0.178018884482021	0.474266629625725	19	17	7515	9661	1.2057487537976
R-HSA-5655253	Signaling by FGFR2 in disease	 36	0.277728703317073	0.616979587748688	18	18	7516	9660	1.14228829307141
R-HSA-5655291	Signaling by FGFR4 in disease	 11	0.0514395498033363	0.232971380399626	8	3	7526	9675	1.6615102444675
R-HSA-5655302	Signaling by FGFR1 in disease	 36	0.178018884482021	0.474266629625725	19	17	7515	9661	1.2057487537976
R-HSA-5655332	Signaling by FGFR3 in disease	 20	0.54172056939255	0.873221216334259	9	11	7525	9667	1.02805946376427
R-HSA-5655862	Translesion synthesis by POLK	 16	0.0392297503364459	0.196365632397414	11	5	7523	9673	1.57064640297319
R-HSA-5656121	Translesion synthesis by POLI	 16	0.0392297503364459	0.196365632397414	11	5	7523	9673	1.57064640297319
R-HSA-5656169	Termination of translesion DNA synthesis	 29	0.248309979066001	0.568723018937463	15	14	7519	9664	1.18167754455663
R-HSA-5658442	Regulation of RAS by GAPs	 60	0.0865676962867187	0.30936993975749	32	28	7502	9650	1.21844084594284
R-HSA-5658623	FGFRL1 modulation of FGFR1 signaling	 11	0.99822819409342	1	1	10	7533	9668	0.207688780558438
R-HSA-5660526	Response to metal ions	 10	0.707332905920157	1	4	6	7530	9672	0.913830634457128
R-HSA-5660668	CLEC7A/inflammasome pathway	  5	0.943820880142438	1	1	4	7533	9674	0.456915317228564
R-HSA-5661231	Metallothioneins bind metals	  7	0.885447327934604	1	2	5	7532	9673	0.652736167469377
R-HSA-5661270	Catabolism of glucuronate to xylulose-5-phosphate	  5	0.943820880142438	1	1	4	7533	9674	0.456915317228564
R-HSA-5663084	Diseases of carbohydrate metabolism	  8	0.758299413046526	1	3	5	7531	9673	0.856716219803557
R-HSA-5663213	RHO GTPases Activate WASPs and WAVEs	 34	0.0263632510680803	0.166729749998129	21	13	7513	9665	1.41106200908821
R-HSA-5666185	RHO GTPases Activate Rhotekin and Rhophilins	  9	0.349821097790456	0.703404953699137	5	4	7529	9674	1.26920921452379
R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	 80	0.846295402106387	1	31	49	7503	9629	0.885273427130342
R-HSA-5668599	RHO GTPases Activate NADPH Oxidases	 11	0.983040291455655	1	2	9	7532	9669	0.415377561116876
R-HSA-5668914	Diseases of metabolism	 36	0.531688358369957	0.869215486173459	16	20	7518	9658	1.01536737161903
R-HSA-5669034	TNFs bind their physiological receptors	 17	0.994592539329979	1	3	14	7531	9664	0.403160574025203
R-HSA-5673000	RAF activation	 25	0.00404312440611257	0.0540623492017338	18	7	7516	9671	1.64489514202283
R-HSA-5674135	MAP2K and MAPK activation	 37	0.457145962462264	0.80364685713825	17	20	7517	9658	1.04967032336292
R-HSA-5674400	Constitutive Signaling by AKT1 E17K in Cancer	 25	0.15120514741184	0.430549981996921	14	11	7520	9667	1.27936288823998
R-HSA-5674499	Negative feedback regulation of MAPK pathway	  6	0.235296834252223	0.550864040284059	4	2	7530	9676	1.52305105742855
R-HSA-5675221	Negative regulation of MAPK pathway	 39	0.00116080582676403	0.0250734058581031	27	12	7507	9666	1.58162994425272
R-HSA-5675482	Regulation of necroptotic cell death	 17	0.828321512294211	1	6	11	7528	9667	0.806321148050407
R-HSA-5676590	NIK-->noncanonical NF-kB signaling	 51	0.18439097869834	0.489385508681418	26	25	7508	9653	1.16468610273948
R-HSA-5676594	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	 15	0.997756914874439	1	2	13	7532	9665	0.304610211485709
R-HSA-5676934	Protein repair	  6	0.533523591186547	0.869215486173459	3	3	7531	9675	1.14228829307141
R-HSA-5678895	Defective CFTR causes cystic fibrosis	 52	0.147715030862565	0.429382822631557	27	25	7507	9653	1.18622245818954
R-HSA-5682910	LGI-ADAM interactions	 14	0.0346936751821096	0.182804057271934	10	4	7524	9674	1.63184041867344
R-HSA-5683826	Surfactant metabolism	 20	0.84539479476407	1	7	13	7527	9665	0.799601805149987
R-HSA-5684264	MAP3K8 (TPL2)-dependent MAPK1/3 activation	 14	0.101030686306554	0.333910375111037	9	5	7525	9673	1.4686563768061
R-HSA-5685938	HDR through Single Strand Annealing (SSA)	 30	0.000996092601492564	0.023308566874926	22	8	7512	9670	1.6753561631714
R-HSA-5685939	HDR through MMEJ (alt-NHEJ)	  9	0.349821097790456	0.703404953699137	5	4	7529	9674	1.26920921452379
R-HSA-5685942	HDR through Homologous Recombination (HRR)	 51	0.0216542105893873	0.148618046982913	30	21	7504	9657	1.34386858008401
R-HSA-5686938	Regulation of TLR by endogenous ligand	 16	0.998662074929375	1	2	14	7532	9664	0.285572073267852
R-HSA-5687128	MAPK6/MAPK4 signaling	 78	0.00484041176793763	0.0617812556562222	46	32	7488	9646	1.34731439695602
R-HSA-5687613	Diseases associated with surfactant metabolism	  7	0.659294130824154	0.97498346054538	3	4	7531	9674	0.979104251204065
R-HSA-5688849	Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5)	  5	0.943820880142438	1	1	4	7533	9674	0.456915317228564
R-HSA-5688890	Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)	  5	0.943820880142438	1	1	4	7533	9674	0.456915317228564
R-HSA-5689603	UCH proteinases	 78	0.046686625422955	0.220700411090333	42	36	7492	9642	1.23015662330767
R-HSA-5689877	Josephin domain DUBs	 10	0.0883599329364341	0.30936993975749	7	3	7527	9675	1.59920361029997
R-HSA-5689896	Ovarian tumor domain proteases	 34	0.412896078625275	0.753844075929631	16	18	7518	9660	1.07509486406721
R-HSA-5689901	Metalloprotease DUBs	 22	0.108979889132403	0.342213013964338	13	9	7521	9669	1.34997707362985
R-HSA-5690714	CD22 mediated BCR regulation	 14	0.996253727949064	1	2	12	7532	9666	0.326368083734688
R-HSA-5693537	Resolution of D-Loop Structures	 24	0.205200724127283	0.526694363207872	13	11	7521	9667	1.23747898416069
R-HSA-5693554	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	 19	0.290267344867721	0.634790268215391	10	9	7524	9669	1.20240872954885
R-HSA-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	 53	0.574556392723288	0.906378848745501	23	30	7511	9648	0.991420027948771
R-HSA-5693567	HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)	 95	0.207968588670914	0.532824632288254	46	49	7488	9629	1.10621603118494
R-HSA-5693568	Resolution of D-loop Structures through Holliday Junction Intermediates	 24	0.205200724127283	0.526694363207872	13	11	7521	9667	1.23747898416069
R-HSA-5693571	Nonhomologous End-Joining (NHEJ)	 46	0.454402533202458	0.80364685713825	21	25	7513	9653	1.04295887628259
R-HSA-5693579	Homologous DNA Pairing and Strand Exchange	 32	0.00379307337199312	0.0517036409153237	22	10	7512	9668	1.57064640297319
R-HSA-5693606	DNA Double Strand Break Response	 53	0.574556392723288	0.906378848745501	23	30	7511	9648	0.991420027948771
R-HSA-5693607	Processing of DNA double-strand break ends	 69	0.210916733431588	0.535492032075859	34	35	7500	9643	1.12573339027327
R-HSA-5693616	Presynaptic phase of homologous DNA pairing and strand exchange	 30	0.000996092601492564	0.023308566874926	22	8	7512	9670	1.6753561631714
R-HSA-5694530	Cargo concentration in the ER	 29	0.146682114784655	0.429045185745117	16	13	7518	9665	1.26045604752707
R-HSA-5696394	DNA Damage Recognition in GG-NER	 36	0.0046842177053986	0.0614639407325199	24	12	7510	9666	1.52305105742855
R-HSA-5696395	Formation of Incision Complex in GG-NER	 38	0.000611578194493932	0.0178886621889475	27	11	7507	9667	1.62325178489095
R-HSA-5696397	Gap-filling DNA repair synthesis and ligation in GG-NER	 23	0.272032393694362	0.607207441568974	12	11	7522	9667	1.19195300146582
R-HSA-5696398	Nucleotide Excision Repair	100	5.84428037850803e-06	0.000745942695584116	66	34	7468	9644	1.50782054685426
R-HSA-5696399	Global Genome Nucleotide Excision Repair (GG-NER)	 77	0.000143572417249592	0.00592869628877729	50	27	7484	9651	1.48349128970313
R-HSA-5696400	Dual Incision in GG-NER	 36	0.0046842177053986	0.0614639407325199	24	12	7510	9666	1.52305105742855
R-HSA-606279	Deposition of new CENPA-containing nucleosomes at the centromere	 39	0.999371610739557	1	8	31	7526	9647	0.468631094593399
R-HSA-611105	Respiratory electron transport	 82	1.66942110350272e-08	7.81289076439273e-06	61	21	7473	9657	1.69950209456966
R-HSA-622312	Inflammasomes	 17	0.157009680044461	0.430549981996921	10	7	7524	9671	1.34386858008401
R-HSA-622323	Presynaptic nicotinic acetylcholine receptors	  8	1	1	0	8	7534	9670	0
R-HSA-622327	Postsynaptic nicotinic acetylcholine receptors	  8	1	1	0	8	7534	9670	0
R-HSA-629587	Highly sodium permeable acetylcholine nicotinic receptors	  5	1	1	0	5	7534	9673	0
R-HSA-629594	Highly calcium permeable postsynaptic nicotinic acetylcholine receptors	  5	1	1	0	5	7534	9673	0
R-HSA-629597	Highly calcium permeable nicotinic acetylcholine receptors	  5	1	1	0	5	7534	9673	0
R-HSA-629602	Activation of Nicotinic Acetylcholine Receptors	  8	1	1	0	8	7534	9670	0
R-HSA-674695	RNA Polymerase II Pre-transcription Events	 71	0.0972425405859403	0.328193574477549	37	34	7497	9644	1.19055399559555
R-HSA-6781823	Formation of TC-NER Pre-Incision Complex	 46	1.90212591788079e-06	0.000381512112672089	36	10	7498	9668	1.78792950219873
R-HSA-6781827	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	 69	1.29125295885936e-05	0.00151076596186545	48	21	7486	9657	1.58927066862109
R-HSA-6782135	Dual incision in TC-NER	 56	8.00150571643651e-05	0.00419151113715512	39	17	7495	9661	1.59104440820661
R-HSA-6782210	Gap-filling DNA repair synthesis and ligation in TC-NER	 56	0.000232421952306202	0.00881947083886237	38	18	7496	9660	1.55024839773977
R-HSA-6782315	tRNA modification in the nucleus and cytosol	 40	0.0284064013472954	0.173402554311316	24	16	7510	9662	1.37074595168569
R-HSA-6782861	Synthesis of wybutosine at G37 of tRNA(Phe)	  5	0.725062616235642	1	2	3	7532	9675	0.913830634457128
R-HSA-6783310	Fanconi Anemia Pathway	 33	0.0777237669584669	0.28566813102332	19	14	7515	9664	1.31536227687011
R-HSA-6783589	Interleukin-6 family signaling	 22	0.351702476849568	0.703404953699137	11	11	7523	9667	1.14228829307141
R-HSA-6783783	Interleukin-10 signaling	 36	0.999441675499984	1	7	29	7527	9649	0.444223225083326
R-HSA-6784531	tRNA processing in the nucleus	 54	0.00764235537467695	0.0844871413074522	33	21	7501	9657	1.39613013597617
R-HSA-6785631	ERBB2 Regulates Cell Motility	 11	0.335634787499311	0.689943252780429	6	5	7528	9673	1.24613268335063
R-HSA-6785807	Interleukin-4 and 13 signaling	 96	0.999465597719263	1	27	69	7507	9609	0.642537164852668
R-HSA-6787450	tRNA modification in the mitochondrion	  7	0.030735790599841	0.174004233879745	6	1	7528	9677	1.95820850240813
R-HSA-6787639	GDP-fucose biosynthesis	  6	0.82083212876019	1	2	4	7532	9674	0.761525528714273
R-HSA-6788467	IL-6-type cytokine receptor ligand interactions	 15	0.706996874102752	1	6	9	7528	9669	0.913830634457128
R-HSA-6788656	Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism	 37	0.457145962462264	0.80364685713825	17	20	7517	9658	1.04967032336292
R-HSA-6790901	rRNA modification in the nucleus and cytosol	 54	0.0301545858005733	0.174004233879745	31	23	7503	9655	1.31151618834125
R-HSA-6791312	TP53 Regulates Transcription of Cell Cycle Genes	 47	0.885470900742938	1	17	30	7517	9648	0.826336212009105
R-HSA-6793080	rRNA modification in the mitochondrion	  6	0.82083212876019	1	2	4	7532	9674	0.761525528714273
R-HSA-6794361	Neurexins and neuroligins	 53	0.0713165379550506	0.277364042351499	29	24	7505	9654	1.25005133958758
R-HSA-6794362	Protein-protein interactions at synapses	 82	0.0278455766381614	0.172225504845721	45	37	7489	9641	1.25373105337106
R-HSA-6796648	TP53 Regulates Transcription of DNA Repair Genes	 53	0.00220238817769316	0.0355419885227724	34	19	7500	9659	1.46557743261992
R-HSA-6798163	Choline catabolism	  6	0.235296834252223	0.550864040284059	4	2	7530	9676	1.52305105742855
R-HSA-6799198	Complex I biogenesis	 47	0.000220873995055359	0.00861408580715901	33	14	7501	9664	1.60406441154709
R-HSA-6802946	Signaling by moderate kinase activity BRAF mutants	 37	0.330855291515535	0.688179006352314	18	19	7516	9659	1.11141563650191
R-HSA-6802948	Signaling by high-kinase activity BRAF mutants	 33	0.353398003379812	0.703595440855219	16	17	7518	9661	1.10767349631167
R-HSA-6802949	Signaling by RAS mutants	 47	0.194054619414004	0.511168265773474	24	23	7510	9655	1.16659229930697
R-HSA-6802952	Signaling by BRAF and RAF fusions	 56	0.089660544440493	0.313142797001125	30	26	7504	9652	1.22388031400508
R-HSA-6802955	Paradoxical activation of RAF signaling by kinase inactive BRAF	 37	0.330855291515535	0.688179006352314	18	19	7516	9659	1.11141563650191
R-HSA-6802957	Oncogenic MAPK signaling	 69	0.0633782262082109	0.25856117824372	37	32	7497	9646	1.22506280706209
R-HSA-6803157	Antimicrobial peptides	 40	0.999977816691466	1	6	34	7528	9644	0.342686487921423
R-HSA-6803204	TP53 Regulates Transcription of Genes Involved in Cytochrome C Release	 20	0.84539479476407	1	7	13	7527	9665	0.799601805149987
R-HSA-6803205	TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain	 13	0.967259494222963	1	3	10	7531	9668	0.527209981417574
R-HSA-6803207	TP53 Regulates Transcription of Caspase Activators and Caspases	 11	0.78562859921922	1	4	7	7530	9671	0.830755122233752
R-HSA-6803211	TP53 Regulates Transcription of Death Receptors and Ligands	 12	0.999004241166275	1	1	11	7533	9667	0.190381382178568
R-HSA-6803529	FGFR2 alternative splicing	 24	0.020089769576217	0.140964159688353	16	8	7518	9670	1.52305105742855
R-HSA-6804114	TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest	 17	0.927602542634	1	5	12	7529	9666	0.671934290042006
R-HSA-6804115	TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain	 20	0.54172056939255	0.873221216334259	9	11	7525	9667	1.02805946376427
R-HSA-6804116	TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest	 13	0.967259494222963	1	3	10	7531	9668	0.527209981417574
R-HSA-6804756	Regulation of TP53 Activity through Phosphorylation	 81	0.0123632750757824	0.11415828303327	46	35	7488	9643	1.29741386373543
R-HSA-6804757	Regulation of TP53 Degradation	 35	0.0391539035748084	0.196365632397414	21	14	7513	9664	1.37074595168569
R-HSA-6804758	Regulation of TP53 Activity through Acetylation	 30	0.107770258729834	0.342213013964338	17	13	7517	9665	1.29459339881426
R-HSA-6804759	Regulation of TP53 Activity through Association with Co-factors	 12	0.94978336727384	1	3	9	7531	9669	0.571144146535705
R-HSA-6804760	Regulation of TP53 Activity through Methylation	 18	0.219724747898273	0.549899369071613	10	8	7524	9670	1.26920921452379
R-HSA-6805567	Keratinization	 80	0.999999992308054	1	12	68	7522	9610	0.342686487921423
R-HSA-6806003	Regulation of TP53 Expression and Degradation	 36	0.0559450013756492	0.240514003210775	21	15	7513	9663	1.33266967524998
R-HSA-6806667	Metabolism of fat-soluble vitamins	 42	0.997854282032504	1	10	32	7524	9646	0.543946806224481
R-HSA-6806834	Signaling by MET	 72	0.00224596638873729	0.0358333728384904	44	28	7490	9650	1.39613013597617
R-HSA-6807004	Negative regulation of MET activity	 20	0.0162378373591587	0.128974491985449	14	6	7520	9672	1.59920361029997
R-HSA-6807505	RNA polymerase II transcribes snRNA genes	 69	0.00311106006173922	0.0459781929124406	42	27	7492	9651	1.39061183504346
R-HSA-6807878	COPI-mediated anterograde transport	 88	0.00135427735450298	0.0270243833080872	53	35	7481	9643	1.37593817119965
R-HSA-6809371	Formation of the cornified envelope	 66	0.999999972170295	1	9	57	7525	9621	0.311533170837657
R-HSA-6811434	COPI-dependent Golgi-to-ER retrograde traffic	 78	0.293790354004045	0.640499467424968	37	41	7497	9637	1.08370940624723
R-HSA-6811436	COPI-independent Golgi-to-ER retrograde traffic	 45	0.000579827869272578	0.0178886621889475	31	14	7503	9664	1.5738194260095
R-HSA-6811438	Intra-Golgi traffic	 38	0.000611578194493932	0.0178886621889475	27	11	7507	9667	1.62325178489095
R-HSA-6811440	Retrograde transport at the Trans-Golgi-Network	 45	0.00162208213127535	0.0298689098571449	30	15	7504	9663	1.52305105742855
R-HSA-6811555	PI5P Regulates TP53 Acetylation	  9	0.609856710583998	0.941573171689011	4	5	7530	9673	1.01536737161903
R-HSA-6811558	PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling	 80	0.846295402106387	1	31	49	7503	9629	0.885273427130342
R-HSA-6814122	Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding	 36	0.0271602622884933	0.169328534590917	22	14	7512	9664	1.39613013597617
R-HSA-6814848	Glycerophospholipid catabolism	  7	0.659294130824154	0.97498346054538	3	4	7531	9674	0.979104251204065
R-HSA-68616	Assembly of the ORC complex at the origin of replication	  5	0.119239284310492	0.361580896699634	4	1	7530	9677	1.82766126891426
R-HSA-68689	CDC6 association with the ORC:origin complex	  8	0.237373749552604	0.550864040284059	5	3	7529	9675	1.42786036633926
R-HSA-68827	CDT1 association with the CDC6:ORC:origin complex	 48	0.0958801422917291	0.324375228379729	26	22	7508	9656	1.23747898416069
R-HSA-68867	Assembly of the pre-replicative complex	 56	0.209643223359385	0.534211765641994	28	28	7506	9650	1.14228829307141
R-HSA-68874	M/G1 Transition	 71	0.45780613613057	0.80364685713825	32	39	7502	9639	1.02966832051507
R-HSA-68884	Mitotic Telophase/Cytokinesis	 11	0.152970603419355	0.430549981996921	7	4	7527	9674	1.45382146390907
R-HSA-68911	G2 Phase	  5	0.943820880142438	1	1	4	7533	9674	0.456915317228564
R-HSA-68949	Orc1 removal from chromatin	 60	0.199043910062048	0.520698774801731	30	30	7504	9648	1.14228829307141
R-HSA-68952	DNA replication initiation	  7	1	1	0	7	7534	9671	0
R-HSA-68962	Activation of the pre-replicative complex	 27	0.693041064172923	1	11	16	7523	9662	0.930753423984112
R-HSA-69002	DNA Replication Pre-Initiation	 71	0.45780613613057	0.80364685713825	32	39	7502	9639	1.02966832051507
R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6	 42	0.254040880630503	0.576209041042369	21	21	7513	9657	1.14228829307141
R-HSA-69052	Switching of origins to a post-replicative state	 60	0.199043910062048	0.520698774801731	30	30	7504	9648	1.14228829307141
R-HSA-69091	Polymerase switching	 12	0.664572059645248	0.97498346054538	5	7	7529	9671	0.951906910892841
R-HSA-69109	Leading Strand Synthesis	 12	0.664572059645248	0.97498346054538	5	7	7529	9671	0.951906910892841
R-HSA-69166	Removal of the Flap Intermediate	 12	0.846156869006207	1	4	8	7530	9670	0.761525528714273
R-HSA-69183	Processive synthesis on the lagging strand	 13	0.744068200022459	1	5	8	7529	9670	0.878683302362623
R-HSA-69186	Lagging Strand Synthesis	 18	0.219724747898273	0.549899369071613	10	8	7524	9670	1.26920921452379
R-HSA-69190	DNA strand elongation	 29	0.378912596142452	0.713080369766776	14	15	7520	9663	1.10289904158619
R-HSA-69202	Cyclin E associated events during G1/S transition 	 71	0.144663636143293	0.424911600722142	36	35	7498	9643	1.15837686057946
R-HSA-69205	G1/S-Specific Transcription	 22	0.68342125270088	0.995356264307091	9	13	7525	9665	0.934599512512972
R-HSA-69229	Ubiquitin-dependent degradation of Cyclin D1	 42	0.254040880630503	0.576209041042369	21	21	7513	9657	1.14228829307141
R-HSA-69231	Cyclin D associated events in G1	 39	0.0192276410289203	0.140964159688353	24	15	7510	9663	1.4058932837802
R-HSA-69236	G1 Phase	 39	0.0192276410289203	0.140964159688353	24	15	7510	9663	1.4058932837802
R-HSA-69239	Synthesis of DNA	 86	0.266057184222859	0.598628664501433	41	45	7493	9633	1.08915860502158
R-HSA-69273	Cyclin A/B1/B2 associated events during G2/M transition	 21	0.0732464862615547	0.280799596292811	13	8	7521	9670	1.41426169618365
R-HSA-69298	Association of licensing factors with the pre-replicative complex	 10	0.235999778001153	0.550864040284059	6	4	7528	9674	1.37074595168569
R-HSA-69300	Removal of licensing factors from origins	 61	0.233978644793476	0.550864040284059	30	31	7504	9647	1.12356225548008
R-HSA-69304	Regulation of DNA replication	 63	0.311018560767425	0.661844326818712	30	33	7504	9645	1.08789361244896
R-HSA-69306	DNA Replication	 92	0.318127472628716	0.671655596346944	43	49	7491	9629	1.0677912304798
R-HSA-69416	Dimerization of procaspase-8	 11	0.983040291455655	1	2	9	7532	9669	0.415377561116876
R-HSA-69473	G2/M DNA damage checkpoint	 67	0.101298567351135	0.333910375111037	35	32	7499	9646	1.19343553007461
R-HSA-69478	G2/M DNA replication checkpoint	  5	1	1	0	5	7534	9673	0
R-HSA-69541	Stabilization of p53	 49	0.121604912077593	0.366380464714465	26	23	7508	9655	1.21222431101456
R-HSA-69563	p53-Dependent G1 DNA Damage Response	 58	0.204246706786815	0.526694363207872	29	29	7505	9649	1.14228829307141
R-HSA-69580	p53-Dependent G1/S DNA damage checkpoint	 58	0.204246706786815	0.526694363207872	29	29	7505	9649	1.14228829307141
R-HSA-69601	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	 43	0.204452752599866	0.526694363207872	22	21	7512	9657	1.16885313709633
R-HSA-69610	p53-Independent DNA Damage Response	 43	0.204452752599866	0.526694363207872	22	21	7512	9657	1.16885313709633
R-HSA-69613	p53-Independent G1/S DNA damage checkpoint	 43	0.204452752599866	0.526694363207872	22	21	7512	9657	1.16885313709633
R-HSA-69615	G1/S DNA Damage Checkpoints	 58	0.204246706786815	0.526694363207872	29	29	7505	9649	1.14228829307141
R-HSA-69618	Mitotic Spindle Checkpoint	 86	0.0272565874768856	0.169328534590917	47	39	7487	9639	1.24854766917108
R-HSA-69656	Cyclin A:Cdk2-associated events at S phase entry	 70	0.120619136987453	0.364191974904051	36	34	7498	9644	1.17492510144488
R-HSA-70171	Glycolysis	 68	0.000940633592877598	0.0231692906035114	43	25	7491	9653	1.44465872359031
R-HSA-70221	Glycogen breakdown (glycogenolysis)	 18	0.567281174366292	0.901964004186939	8	10	7526	9668	1.01536737161903
R-HSA-70263	Gluconeogenesis	 29	0.248309979066001	0.568723018937463	15	14	7519	9664	1.18167754455663
R-HSA-70268	Pyruvate metabolism	 24	0.020089769576217	0.140964159688353	16	8	7518	9670	1.52305105742855
R-HSA-70326	Glucose metabolism	 85	0.00185825582860135	0.0314336287151361	51	34	7483	9644	1.37074595168569
R-HSA-70350	Fructose catabolism	  5	0.943820880142438	1	1	4	7533	9674	0.456915317228564
R-HSA-70370	Galactose catabolism	  6	0.235296834252223	0.550864040284059	4	2	7530	9676	1.52305105742855
R-HSA-70614	Amino acid synthesis and interconversion (transamination)	 30	0.0243561581720445	0.15614632910297	19	11	7515	9667	1.44689850455712
R-HSA-70635	Urea cycle	  6	0.968418630418888	1	1	5	7533	9673	0.380762764357137
R-HSA-70895	Branched-chain amino acid catabolism	 20	0.00105700688317205	0.0239360913544122	16	4	7518	9674	1.82766126891426
R-HSA-70921	Histidine catabolism	  5	0.725062616235642	1	2	3	7532	9675	0.913830634457128
R-HSA-71032	Propionyl-CoA catabolism	  5	0.0160563628551145	0.128974491985449	5	0	7529	9678	2.28457658614282
R-HSA-71064	Lysine catabolism	 11	0.0514395498033363	0.232971380399626	8	3	7526	9675	1.6615102444675
R-HSA-71182	Phenylalanine and tyrosine catabolism	  9	0.832520764277791	1	3	6	7531	9672	0.761525528714273
R-HSA-71240	Tryptophan catabolism	 11	0.335634787499311	0.689943252780429	6	5	7528	9673	1.24613268335063
R-HSA-71288	Creatine metabolism	  8	0.494285327120202	0.836116384670799	4	4	7530	9674	1.14228829307141
R-HSA-71336	Pentose phosphate pathway (hexose monophosphate shunt)	 13	0.322830446624098	0.675490234068904	7	6	7527	9672	1.23015662330767
R-HSA-71384	Ethanol oxidation	 10	0.886172703573919	1	3	7	7531	9671	0.685372975842846
R-HSA-71403	Citric acid cycle (TCA cycle)	 18	9.55330173710568e-05	0.00419151113715512	16	2	7518	9676	2.03073474323806
R-HSA-71406	Pyruvate metabolism and Citric Acid (TCA) cycle	 44	9.36535713709797e-05	0.00419151113715512	32	12	7502	9666	1.6615102444675
R-HSA-72086	mRNA Capping	 24	0.00678226678878488	0.0774170940768616	17	7	7517	9671	1.61824174851783
R-HSA-72165	mRNA Splicing - Minor Pathway	 48	0.0958801422917291	0.324375228379729	26	22	7508	9656	1.23747898416069
R-HSA-72187	mRNA 3'-end processing	 50	0.000463120278614908	0.0151214156087286	34	16	7500	9662	1.55351207857712
R-HSA-72202	Transport of Mature Transcript to Cytoplasm	 72	0.00103678677296025	0.0238630922825605	45	27	7489	9651	1.42786036633926
R-HSA-72306	tRNA processing	 99	0.000256736234754414	0.00924250445115889	61	38	7473	9640	1.40766840156275
R-HSA-72613	Eukaryotic Translation Initiation	 73	0.355868715637347	0.703595440855219	34	39	7500	9639	1.06404936888844
R-HSA-72649	Translation initiation complex formation	 37	0.221650637996474	0.550766050641046	19	18	7515	9660	1.17316094964091
R-HSA-72662	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	 38	0.269439993213317	0.603339314946565	19	19	7515	9659	1.14228829307141
R-HSA-72689	Formation of a pool of free 40S subunits	 56	0.393065034481152	0.725181745613057	26	30	7508	9648	1.06069627213774
R-HSA-72695	Formation of the ternary complex, and subsequently, the 43S complex	 31	0.241177807257612	0.556930331233038	16	15	7518	9663	1.17913630252533
R-HSA-72702	Ribosomal scanning and start codon recognition	 37	0.221650637996474	0.550766050641046	19	18	7515	9660	1.17316094964091
R-HSA-72706	GTP hydrolysis and joining of the 60S ribosomal subunit	 66	0.437763985391676	0.788030825997375	30	36	7504	9642	1.03844390279219
R-HSA-72731	Recycling of eIF2:GDP	  8	0.494285327120202	0.836116384670799	4	4	7530	9674	1.14228829307141
R-HSA-72737	Cap-dependent Translation Initiation	 73	0.355868715637347	0.703595440855219	34	39	7500	9639	1.06404936888844
R-HSA-72764	Eukaryotic Translation Termination	 50	0.428268866636926	0.773860345892206	23	27	7511	9651	1.0509052296257
R-HSA-727802	Transport of nucleotide sugars	  7	0.030735790599841	0.174004233879745	6	1	7528	9677	1.95820850240813
R-HSA-73614	Pyrimidine salvage	 10	0.707332905920157	1	4	6	7530	9672	0.913830634457128
R-HSA-73621	Pyrimidine catabolism	  9	0.832520764277791	1	3	6	7531	9672	0.761525528714273
R-HSA-73728	RNA Polymerase I Promoter Opening	 27	0.999996147290553	1	2	25	7532	9653	0.169227895269838
R-HSA-73762	RNA Polymerase I Transcription Initiation	 44	0.0292627845524285	0.174004233879745	26	18	7508	9660	1.34997707362985
R-HSA-73772	RNA Polymerase I Promoter Escape	 27	0.0350068483079032	0.182804057271934	17	10	7517	9668	1.43843710979363
R-HSA-73776	RNA Polymerase II Promoter Escape	 40	0.0561884565905513	0.240514003210775	23	17	7511	9661	1.31363153703212
R-HSA-73777	RNA Polymerase I Chain Elongation	 51	0.860402140186158	1	19	32	7515	9646	0.851116767386541
R-HSA-73779	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	 40	0.0561884565905513	0.240514003210775	23	17	7511	9661	1.31363153703212
R-HSA-73780	RNA Polymerase III Chain Elongation	 17	0.0678039646689028	0.268159905338421	11	6	7523	9672	1.47825543809241
R-HSA-73817	Purine ribonucleoside monophosphate biosynthesis	 11	0.923876742706931	1	3	8	7531	9670	0.623066341675314
R-HSA-73854	RNA Polymerase I Promoter Clearance	 70	0.775043698480811	1	28	42	7506	9636	0.913830634457128
R-HSA-73856	RNA Polymerase II Transcription Termination	 58	0.0016593838809525	0.0298689098571449	37	21	7497	9657	1.45740230495318
R-HSA-73863	RNA Polymerase I Transcription Termination	 28	0.023116913119135	0.150958818694258	18	10	7516	9668	1.4686563768061
R-HSA-73864	RNA Polymerase I Transcription	 72	0.682816400885554	0.995356264307091	30	42	7504	9636	0.951906910892841
R-HSA-73884	Base Excision Repair	 37	0.00297440277639728	0.0453919728050193	25	12	7509	9666	1.54363282847488
R-HSA-73886	Chromosome Maintenance	 73	0.988280950673632	1	23	50	7511	9628	0.719798102483354
R-HSA-73887	Death Receptor Signalling	 45	0.199156155319466	0.520698774801731	23	22	7511	9656	1.16767247736189
R-HSA-73893	DNA Damage Bypass	 44	0.0989258139437467	0.330697456034919	24	20	7510	9658	1.24613268335063
R-HSA-73928	Depyrimidination	  8	0.0151772407427947	0.125346152958139	7	1	7527	9677	1.99900451287497
R-HSA-73929	Base-Excision Repair, AP Site Formation	 10	0.00356682631174566	0.0495692091466413	9	1	7525	9677	2.05611892752854
R-HSA-73933	Resolution of Abasic Sites (AP sites)	 37	0.00297440277639728	0.0453919728050193	25	12	7509	9666	1.54363282847488
R-HSA-73942	DNA Damage Reversal	  8	0.92782996623063	1	2	6	7532	9672	0.571144146535705
R-HSA-73943	Reversal of alkylation damage by DNA dioxygenases	  7	0.885447327934604	1	2	5	7532	9673	0.652736167469377
R-HSA-73980	RNA Polymerase III Transcription Termination	 22	0.00573347924512929	0.0693948694841511	16	6	7518	9672	1.6615102444675
R-HSA-74158	RNA Polymerase III Transcription	 39	0.00116080582676403	0.0250734058581031	27	12	7507	9666	1.58162994425272
R-HSA-74182	Ketone body metabolism	  8	0.0774114401709801	0.28566813102332	6	2	7528	9676	1.71343243960711
R-HSA-74217	Purine salvage	 13	0.155841638600134	0.430549981996921	8	5	7526	9673	1.4058932837802
R-HSA-74259	Purine catabolism	 16	0.595758040689229	0.931452437781378	7	9	7527	9669	0.999502256437483
R-HSA-74713	IRS activation	  5	0.119239284310492	0.361580896699634	4	1	7530	9677	1.82766126891426
R-HSA-74749	Signal attenuation	 10	0.0883599329364341	0.30936993975749	7	3	7527	9675	1.59920361029997
R-HSA-749476	RNA Polymerase III Abortive And Retractive Initiation	 39	0.00116080582676403	0.0250734058581031	27	12	7507	9666	1.58162994425272
R-HSA-75035	Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex	 11	0.570315442646798	0.901964004186939	5	6	7529	9672	1.03844390279219
R-HSA-75067	Processing of Capped Intronless Pre-mRNA	 26	0.109011636070538	0.342213013964338	15	11	7519	9667	1.31802495354393
R-HSA-75072	mRNA Editing	  5	0.725062616235642	1	2	3	7532	9675	0.913830634457128
R-HSA-75105	Fatty acyl-CoA biosynthesis	 33	0.00233779295204115	0.0368793405018626	23	10	7511	9668	1.59228065094803
R-HSA-75109	Triglyceride biosynthesis	  8	0.494285327120202	0.836116384670799	4	4	7530	9674	1.14228829307141
R-HSA-75153	Apoptotic execution  phase	 45	0.638389283056118	0.972124244480249	19	26	7515	9652	0.964599003038079
R-HSA-75157	FasL/ CD95L signaling	  5	1	1	0	5	7534	9673	0
R-HSA-75158	TRAIL  signaling	  7	0.885447327934604	1	2	5	7532	9673	0.652736167469377
R-HSA-75205	Dissolution of Fibrin Clot	 10	0.996847475671805	1	1	9	7533	9669	0.228457658614282
R-HSA-75815	Ubiquitin-dependent degradation of Cyclin D	 42	0.254040880630503	0.576209041042369	21	21	7513	9657	1.14228829307141
R-HSA-75876	Synthesis of very long-chain fatty acyl-CoAs	 21	0.00972315716368701	0.0975093761272612	15	6	7519	9672	1.63184041867344
R-HSA-75892	Platelet Adhesion to exposed collagen	 10	0.886172703573919	1	3	7	7531	9671	0.685372975842846
R-HSA-75893	TNF signaling	 38	0.103223569688154	0.338611896827496	21	17	7513	9661	1.26252916602629
R-HSA-75953	RNA Polymerase II Transcription Initiation	 40	0.0561884565905513	0.240514003210775	23	17	7511	9661	1.31363153703212
R-HSA-75955	RNA Polymerase II Transcription Elongation	 50	0.0550573091564467	0.240514003210775	28	22	7506	9656	1.27936288823998
R-HSA-76009	Platelet Aggregation (Plug Formation)	 32	0.977405311918894	1	9	23	7525	9655	0.642537164852668
R-HSA-76042	RNA Polymerase II Transcription Initiation And Promoter Clearance	 40	0.0561884565905513	0.240514003210775	23	17	7511	9661	1.31363153703212
R-HSA-76046	RNA Polymerase III Transcription Initiation	 34	0.0112076843317071	0.109376485249807	22	12	7512	9666	1.47825543809241
R-HSA-76061	RNA Polymerase III Transcription Initiation From Type 1 Promoter	 26	0.0216999285124624	0.148618046982913	17	9	7517	9669	1.49376161401646
R-HSA-76066	RNA Polymerase III Transcription Initiation From Type 2 Promoter	 25	0.033399681086001	0.182804057271934	16	9	7518	9669	1.4621290151314
R-HSA-76071	RNA Polymerase III Transcription Initiation From Type 3 Promoter	 27	0.0138723286327914	0.121190695524412	18	9	7516	9669	1.52305105742855
R-HSA-77075	RNA Pol II CTD phosphorylation and interaction with CE	 22	0.00573347924512929	0.0693948694841511	16	6	7518	9672	1.6615102444675
R-HSA-77111	Synthesis of Ketone Bodies	  7	0.137397306189089	0.406117511346276	5	2	7529	9676	1.63184041867344
R-HSA-77286	mitochondrial fatty acid beta-oxidation of saturated fatty acids	 10	0.463642417579759	0.80364685713825	5	5	7529	9673	1.14228829307141
R-HSA-77288	mitochondrial fatty acid beta-oxidation of unsaturated fatty acids	  6	0.82083212876019	1	2	4	7532	9674	0.761525528714273
R-HSA-77289	Mitochondrial Fatty Acid Beta-Oxidation	 30	0.054356302887927	0.240514003210775	18	12	7516	9666	1.37074595168569
R-HSA-77310	Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA	  5	0.384410212719386	0.713080369766776	3	2	7531	9676	1.37074595168569
R-HSA-77346	Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA	  6	0.0612105093396261	0.252763397390692	5	1	7529	9677	1.90381382178568
R-HSA-77348	Beta oxidation of octanoyl-CoA to hexanoyl-CoA	  5	0.119239284310492	0.361580896699634	4	1	7530	9677	1.82766126891426
R-HSA-77350	Beta oxidation of hexanoyl-CoA to butanoyl-CoA	  5	0.384410212719386	0.713080369766776	3	2	7531	9676	1.37074595168569
R-HSA-77387	Insulin receptor recycling	 22	0.000298976459236922	0.010494073719216	18	4	7516	9674	1.86919902502594
R-HSA-774815	Nucleosome assembly	 39	0.999371610739557	1	8	31	7526	9647	0.468631094593399
R-HSA-77588	SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs	 10	0.707332905920157	1	4	6	7530	9672	0.913830634457128
R-HSA-77595	Processing of Intronless Pre-mRNAs	 18	0.0429643621554877	0.20517674988539	12	6	7522	9672	1.52305105742855
R-HSA-804914	Transport of fatty acids	  6	0.82083212876019	1	2	4	7532	9674	0.761525528714273
R-HSA-83936	Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane	  6	0.82083212876019	1	2	4	7532	9674	0.761525528714273
R-HSA-844456	The NLRP3 inflammasome	 12	0.438356178848967	0.788030825997375	6	6	7528	9672	1.14228829307141
R-HSA-877300	Interferon gamma signaling	 70	0.958905816072561	1	24	46	7510	9632	0.783283400963252
R-HSA-877312	Regulation of IFNG signaling	 13	0.322830446624098	0.675490234068904	7	6	7527	9672	1.23015662330767
R-HSA-879415	Advanced glycosylation endproduct receptor signaling	 12	0.664572059645248	0.97498346054538	5	7	7529	9671	0.951906910892841
R-HSA-879518	Transport of organic anions	  9	0.832520764277791	1	3	6	7531	9672	0.761525528714273
R-HSA-8847993	ERBB2 Activates PTK6 Signaling	 10	0.0883599329364341	0.30936993975749	7	3	7527	9675	1.59920361029997
R-HSA-8848021	Signaling by PTK6	 52	0.0927757609742867	0.320830464058864	28	24	7506	9654	1.23015662330767
R-HSA-8849469	PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1	  8	0.494285327120202	0.836116384670799	4	4	7530	9674	1.14228829307141
R-HSA-8849470	PTK6 Regulates Cell Cycle	  5	0.943820880142438	1	1	4	7533	9674	0.456915317228564
R-HSA-8849471	PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases	 18	0.0139835417912783	0.121190695524412	13	5	7521	9673	1.64997197888093
R-HSA-8849473	PTK6 Expression	  5	0.725062616235642	1	2	3	7532	9675	0.913830634457128
R-HSA-8849932	Synaptic adhesion-like molecules	 19	0.0709112367691535	0.276553823399698	12	7	7522	9671	1.44289047545862
R-HSA-8850843	Phosphate bond hydrolysis by NTPDase proteins	  7	0.659294130824154	0.97498346054538	3	4	7531	9674	0.979104251204065
R-HSA-8851680	Butyrophilin (BTN) family interactions	  9	0.609856710583998	0.941573171689011	4	5	7530	9673	1.01536737161903
R-HSA-8851708	Signaling by FGFR2 IIIa TM	 17	0.157009680044461	0.430549981996921	10	7	7524	9671	1.34386858008401
R-HSA-8851805	MET activates RAS signaling	 10	0.235999778001153	0.550864040284059	6	4	7528	9674	1.37074595168569
R-HSA-8851907	MET activates PI3K/AKT signaling	  6	0.533523591186547	0.869215486173459	3	3	7531	9675	1.14228829307141
R-HSA-8852135	Protein ubiquitination	 65	0.155293809500665	0.430549981996921	33	32	7501	9646	1.15986195911866
R-HSA-8852276	The role of GTSE1 in G2/M progression after G2 checkpoint	 64	0.449195707212012	0.802380118226037	29	35	7505	9643	1.03519876559596
R-HSA-8853334	Signaling by FGFR3 fusions in cancer	 10	0.0227160641348271	0.14903436469765	8	2	7526	9676	1.82766126891426
R-HSA-8853338	Signaling by FGFR3 point mutants in cancer	 20	0.54172056939255	0.873221216334259	9	11	7525	9667	1.02805946376427
R-HSA-8854050	FBXL7 down-regulates AURKA during mitotic entry and in early mitosis	 47	0.12405582818506	0.372964417070287	25	22	7509	9656	1.2152003117781
R-HSA-8854214	TBC/RABGAPs	 39	0.00328207685507626	0.0475055247889388	26	13	7508	9665	1.52305105742855
R-HSA-8854518	AURKA Activation by TPX2	 69	0.00311106006173922	0.0459781929124406	42	27	7492	9651	1.39061183504346
R-HSA-8856825	Cargo recognition for clathrin-mediated endocytosis	 95	2.81781286654302e-06	0.0004945261580783	64	31	7470	9647	1.53908317382253
R-HSA-8857538	PTK6 promotes HIF1A stabilization	  6	0.235296834252223	0.550864040284059	4	2	7530	9676	1.52305105742855
R-HSA-8862803	Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models	 20	0.0460212124211317	0.218289804862395	13	7	7521	9671	1.48497478099283
R-HSA-8863678	Neurodegenerative Diseases	 20	0.0460212124211317	0.218289804862395	13	7	7521	9671	1.48497478099283
R-HSA-8863795	Downregulation of ERBB2 signaling	 25	0.0126029443519635	0.11415828303327	17	8	7517	9670	1.55351207857712
R-HSA-8864260	Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors	 30	0.958293530190699	1	9	21	7525	9657	0.685372975842846
R-HSA-8865999	MET activates PTPN11	  5	0.384410212719386	0.713080369766776	3	2	7531	9676	1.37074595168569
R-HSA-8866376	Reelin signalling pathway	  7	0.365829538336403	0.703595440855219	4	3	7530	9675	1.30547233493875
R-HSA-8866427	VLDLR internalisation and degradation	 12	0.0292250203990059	0.174004233879745	9	3	7525	9675	1.71343243960711
R-HSA-8866652	Synthesis of active ubiquitin: roles of E1 and E2 enzymes	 26	0.0216999285124624	0.148618046982913	17	9	7517	9669	1.49376161401646
R-HSA-8866654	E3 ubiquitin ligases ubiquitinate target proteins	 48	0.556664215776438	0.891170534720775	21	27	7513	9651	0.999502256437483
R-HSA-8866904	Negative regulation of activity of TFAP2 (AP-2) family transcription factors	  8	0.990021068633265	1	1	7	7533	9671	0.285572073267852
R-HSA-8866907	Activation of the TFAP2 (AP-2) family of transcription factors	 10	0.707332905920157	1	4	6	7530	9672	0.913830634457128
R-HSA-8866910	TFAP2 (AP-2) family regulates transcription of growth factors and their receptors	  9	0.349821097790456	0.703404953699137	5	4	7529	9674	1.26920921452379
R-HSA-8868766	rRNA processing in the mitochondrion	  8	0.758299413046526	1	3	5	7531	9673	0.856716219803557
R-HSA-8873719	RAB geranylgeranylation	 55	0.00095947019365054	0.0232257957221613	36	19	7498	9659	1.49535922002075
R-HSA-8874081	MET activates PTK2 signaling	 28	0.610278907576211	0.941573171689011	12	16	7522	9662	0.979104251204065
R-HSA-8874211	CREB3 factors activate genes	  7	0.365829538336403	0.703595440855219	4	3	7530	9675	1.30547233493875
R-HSA-8875360	InlB-mediated entry of Listeria monocytogenes into host cell	 14	0.00889328192640117	0.0931803569005018	11	3	7523	9675	1.79502446054079
R-HSA-8875513	MET interacts with TNS proteins	  5	0.943820880142438	1	1	4	7533	9674	0.456915317228564
R-HSA-8875555	MET activates RAP1 and RAC1	 10	0.235999778001153	0.550864040284059	6	4	7528	9674	1.37074595168569
R-HSA-8875656	MET receptor recycling	 10	0.0227160641348271	0.14903436469765	8	2	7526	9676	1.82766126891426
R-HSA-8875878	MET promotes cell motility	 38	0.269439993213317	0.603339314946565	19	19	7515	9659	1.14228829307141
R-HSA-8876198	RAB GEFs exchange GTP for GDP on RABs	 83	0.00360118186108078	0.0495692091466413	49	34	7485	9644	1.34872593639757
R-HSA-8876384	Listeria monocytogenes entry into host cells	 18	0.0429643621554877	0.20517674988539	12	6	7522	9672	1.52305105742855
R-HSA-8876493	InlA-mediated entry of Listeria monocytogenes into host cells	  7	0.659294130824154	0.97498346054538	3	4	7531	9674	0.979104251204065
R-HSA-8876725	Protein methylation	 17	0.300316735426027	0.649683661846135	9	8	7525	9670	1.20948172207561
R-HSA-8877330	RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs)	  7	0.982247180832935	1	1	6	7533	9672	0.326368083734688
R-HSA-888590	GABA synthesis, release, reuptake and degradation	 18	9.55330173710568e-05	0.00419151113715512	16	2	7518	9676	2.03073474323806
R-HSA-8931987	RUNX1 regulates estrogen receptor mediated transcription	  5	0.725062616235642	1	2	3	7532	9675	0.913830634457128
R-HSA-8934593	Regulation of RUNX1 Expression and Activity	 17	0.0678039646689028	0.268159905338421	11	6	7523	9672	1.47825543809241
R-HSA-8934903	Receptor Mediated Mitophagy	 10	0.0883599329364341	0.30936993975749	7	3	7527	9675	1.59920361029997
R-HSA-8935690	Digestion	 11	1	1	0	11	7534	9667	0
R-HSA-8935964	RUNX1 regulates expression of components of tight junctions	  5	1	1	0	5	7534	9673	0
R-HSA-8936459	RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function	 59	0.872673216589648	1	22	37	7512	9641	0.851876015171899
R-HSA-8937144	Aryl hydrocarbon receptor signalling	  7	0.885447327934604	1	2	5	7532	9673	0.652736167469377
R-HSA-8939236	RUNX1 regulates transcription of genes involved in differentiation of HSCs	 83	0.936125214122171	1	30	53	7504	9625	0.825750573304634
R-HSA-8939242	RUNX1 regulates transcription of genes involved in differentiation of keratinocytes	  7	0.982247180832935	1	1	6	7533	9672	0.326368083734688
R-HSA-8939243	RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known	 35	0.34179660606728	0.697503539125671	17	18	7517	9660	1.10965148469794
R-HSA-8939245	RUNX1 regulates transcription of genes involved in BCR signaling	  5	0.943820880142438	1	1	4	7533	9674	0.456915317228564
R-HSA-8939246	RUNX1 regulates transcription of genes involved in differentiation of myeloid cells	  5	0.725062616235642	1	2	3	7532	9675	0.913830634457128
R-HSA-8939256	RUNX1 regulates transcription of genes involved in WNT signaling	  5	1	1	0	5	7534	9673	0
R-HSA-8941855	RUNX3 regulates CDKN1A transcription	  7	0.885447327934604	1	2	5	7532	9673	0.652736167469377
R-HSA-8941856	RUNX3 regulates NOTCH signaling	 13	0.322830446624098	0.675490234068904	7	6	7527	9672	1.23015662330767
R-HSA-8941858	Regulation of RUNX3 expression and activity	 49	0.491653097304577	0.836116384670799	22	27	7512	9651	1.02572826316616
R-HSA-8943723	Regulation of PTEN mRNA translation	  9	0.000588275854857971	0.0178886621889475	9	0	7525	9678	2.28457658614282
R-HSA-8943724	Regulation of PTEN gene transcription	 57	0.171098724023094	0.458215557827077	29	28	7505	9650	1.16232843856389
R-HSA-8948216	Collagen chain trimerization	 35	0.472769318674114	0.817448427855241	16	19	7518	9659	1.044377867951
R-HSA-8948700	Competing endogenous RNAs (ceRNAs) regulate PTEN translation	  8	0.00134476452391397	0.0270243833080872	8	0	7526	9678	2.28457658614282
R-HSA-8948747	Regulation of PTEN localization	  8	0.0774114401709801	0.28566813102332	6	2	7528	9676	1.71343243960711
R-HSA-8948751	Regulation of PTEN stability and activity	 60	0.0865676962867187	0.30936993975749	32	28	7502	9650	1.21844084594284
R-HSA-8949215	Mitochondrial calcium ion transport	 22	0.108979889132403	0.342213013964338	13	9	7521	9669	1.34997707362985
R-HSA-8949275	RUNX3 Regulates Immune Response and Cell Migration	  5	1	1	0	5	7534	9673	0
R-HSA-8949613	Cristae formation	 26	2.16595050861488e-05	0.00217213893863949	22	4	7512	9674	1.93310326519777
R-HSA-8949664	Processing of SMDT1	 16	0.224448294341669	0.550864040284059	9	7	7525	9671	1.28507432970534
R-HSA-8950505	Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation	 27	0.0770101025065856	0.28566813102332	16	11	7518	9667	1.35382316215871
R-HSA-8951430	RUNX3 regulates WNT signaling	  9	0.609856710583998	0.941573171689011	4	5	7530	9673	1.01536737161903
R-HSA-8951671	RUNX3 regulates YAP1-mediated transcription	 22	0.0182724669891678	0.137927654047267	15	7	7519	9671	1.55766585418829
R-HSA-8951936	RUNX3 regulates p14-ARF	 10	0.972283282592251	1	2	8	7532	9670	0.456915317228564
R-HSA-8952158	RUNX3 regulates BCL2L11 (BIM) transcription	  5	0.384410212719386	0.713080369766776	3	2	7531	9676	1.37074595168569
R-HSA-8955332	Carboxyterminal post-translational modifications of tubulin	 32	0.18666577806572	0.494488212083531	17	15	7517	9663	1.21368131138837
R-HSA-8956319	Nucleobase catabolism	 30	0.588869694598551	0.925646804661546	13	17	7521	9661	0.989983187328555
R-HSA-8956320	Nucleobase biosynthesis	 14	0.924689780102498	1	4	10	7530	9668	0.652736167469377
R-HSA-8956321	Nucleotide salvage	 22	0.210031976235314	0.534211765641994	12	10	7522	9668	1.24613268335063
R-HSA-8957275	Post-translational protein phosphorylation	 93	0.904041894497898	1	35	58	7499	9620	0.85978688725805
R-HSA-8963743	Digestion and absorption	 13	1	1	0	13	7534	9665	0
R-HSA-8963888	Chylomicron assembly	  6	0.968418630418888	1	1	5	7533	9673	0.380762764357137
R-HSA-8963889	Assembly of active LPL and LIPC lipase complexes	 14	0.978869416255817	1	3	11	7531	9667	0.489552125602033
R-HSA-8963896	HDL assembly	  8	0.494285327120202	0.836116384670799	4	4	7530	9674	1.14228829307141
R-HSA-8963898	Plasma lipoprotein assembly	 14	0.80862918746242	1	5	9	7529	9669	0.815920209336721
R-HSA-8963899	Plasma lipoprotein remodeling	 22	0.988774381285425	1	5	17	7529	9661	0.519221951396095
R-HSA-8963901	Chylomicron remodeling	  6	1	1	0	6	7534	9672	0
R-HSA-8964038	LDL clearance	 19	0.0709112367691535	0.276553823399698	12	7	7522	9671	1.44289047545862
R-HSA-8964043	Plasma lipoprotein clearance	 29	0.248309979066001	0.568723018937463	15	14	7519	9664	1.18167754455663
R-HSA-8964058	HDL remodeling	  7	0.885447327934604	1	2	5	7532	9673	0.652736167469377
R-HSA-8978934	Metabolism of cofactors	  8	0.494285327120202	0.836116384670799	4	4	7530	9674	1.14228829307141
R-HSA-8979227	Triglyceride metabolism	 29	0.944104956657488	1	9	20	7525	9658	0.709006526733978
R-HSA-8982491	Glycogen metabolism	 26	0.47792638167712	0.822314509650338	12	14	7522	9664	1.05441996283515
R-HSA-8984722	Interleukin-35 Signalling	  6	0.235296834252223	0.550864040284059	4	2	7530	9676	1.52305105742855
R-HSA-901032	ER Quality Control Compartment (ERQC)	 19	0.00195725012250191	0.0323291667293257	15	4	7519	9674	1.80361309432328
R-HSA-901042	Calnexin/calreticulin cycle	 24	8.16615121821187e-05	0.00419151113715512	20	4	7514	9674	1.90381382178568
R-HSA-909733	Interferon alpha/beta signaling	 53	0.997088409801729	1	14	39	7520	9639	0.603473060490556
R-HSA-912446	Meiotic recombination	 40	0.988855384279736	1	11	29	7523	9649	0.628258561189275
R-HSA-912631	Regulation of signaling by CBL	 20	0.365643666811852	0.703595440855219	10	10	7524	9668	1.14228829307141
R-HSA-912694	Regulation of IFNA signaling	 14	0.41673798492329	0.754967910751354	7	7	7527	9671	1.14228829307141
R-HSA-913709	O-linked glycosylation of mucins	 54	0.988529228974449	1	16	38	7518	9640	0.676911581079354
R-HSA-917729	Endosomal Sorting Complex Required For Transport (ESCRT)	 28	0.315863056864165	0.667879114212783	14	14	7520	9664	1.14228829307141
R-HSA-917937	Iron uptake and transport	 50	4.89213944124741e-05	0.00387474816258222	36	14	7498	9664	1.64489514202283
R-HSA-917977	Transferrin endocytosis and recycling	 27	6.83494112612948e-05	0.00419151113715512	22	5	7512	9673	1.86150684796822
R-HSA-918233	TRAF3-dependent IRF activation pathway	 13	0.744068200022459	1	5	8	7529	9670	0.878683302362623
R-HSA-927802	Nonsense-Mediated Decay (NMD)	 72	0.171341287649014	0.458215557827077	36	36	7498	9642	1.14228829307141
R-HSA-933541	TRAF6 mediated IRF7 activation	 21	0.883074554727646	1	7	14	7527	9664	0.761525528714273
R-HSA-933542	TRAF6 mediated NF-kB activation	 24	0.794381484794173	1	9	15	7525	9663	0.856716219803557
R-HSA-933543	NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10	 11	0.78562859921922	1	4	7	7530	9671	0.830755122233752
R-HSA-936440	Negative regulators of DDX58/IFIH1 signaling	 31	0.0777245199792794	0.28566813102332	18	13	7516	9665	1.32652834034099
R-HSA-936837	Ion transport by P-type ATPases	 52	0.0927757609742867	0.320830464058864	28	24	7506	9654	1.23015662330767
R-HSA-936964	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	 15	0.311123401495976	0.661844326818712	8	7	7526	9671	1.21844084594284
R-HSA-937039	IRAK1 recruits IKK complex	 11	0.335634787499311	0.689943252780429	6	5	7528	9673	1.24613268335063
R-HSA-937041	IKK complex recruitment mediated by RIP1	 20	0.365643666811852	0.703595440855219	10	10	7524	9668	1.14228829307141
R-HSA-937042	IRAK2 mediated activation of TAK1 complex	  9	0.147415870962322	0.429382822631557	6	3	7528	9675	1.52305105742855
R-HSA-937061	TRIF-mediated TLR3/TLR4 signaling 	 94	0.0412670833980645	0.201177031565564	50	44	7484	9634	1.2152003117781
R-HSA-937072	TRAF6 mediated induction of TAK1 complex	 15	0.311123401495976	0.661844326818712	8	7	7526	9671	1.21844084594284
R-HSA-964739	N-glycan trimming and elongation in the cis-Golgi	  5	0.384410212719386	0.713080369766776	3	2	7531	9676	1.37074595168569
R-HSA-975110	TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling	 12	0.664572059645248	0.97498346054538	5	7	7529	9671	0.951906910892841
R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	 86	0.101314686465315	0.333910375111037	44	42	7490	9636	1.16885313709633
R-HSA-975144	IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation	 11	0.335634787499311	0.689943252780429	6	5	7528	9673	1.24613268335063
R-HSA-975155	MyD88 dependent cascade initiated on endosome	 88	0.0991621289107556	0.330697456034919	45	43	7489	9635	1.16824939064121
R-HSA-975163	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	 14	0.41673798492329	0.754967910751354	7	7	7527	9671	1.14228829307141
R-HSA-975298	Ligand-gated ion channel transport	 15	0.311123401495976	0.661844326818712	8	7	7526	9671	1.21844084594284
R-HSA-975576	N-glycan antennae elongation in the medial/trans-Golgi	 25	0.408250030362142	0.746332086755791	12	13	7522	9665	1.09659676134855
R-HSA-975577	N-Glycan antennae elongation	 14	0.41673798492329	0.754967910751354	7	7	7527	9671	1.14228829307141
R-HSA-975578	Reactions specific to the complex N-glycan synthesis pathway	 10	0.463642417579759	0.80364685713825	5	5	7529	9673	1.14228829307141
R-HSA-975634	Retinoid metabolism and transport	 39	0.994000737368152	1	10	29	7524	9649	0.585788868241749
R-HSA-975871	MyD88 cascade initiated on plasma membrane	 81	0.0573876942480413	0.242687719048946	43	38	7491	9640	1.21279991610051
R-HSA-975956	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	 52	0.311860714347094	0.662409142123026	25	27	7509	9651	1.09835412795328
R-HSA-975957	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	 72	0.171341287649014	0.458215557827077	36	36	7498	9642	1.14228829307141
R-HSA-977068	Termination of O-glycan biosynthesis	 17	0.999204679675961	1	2	15	7532	9663	0.268773716016802
R-HSA-977225	Amyloid fiber formation	 56	0.985953469342953	1	17	39	7517	9639	0.693532177936213
R-HSA-977347	Serine biosynthesis	  7	0.659294130824154	0.97498346054538	3	4	7531	9674	0.979104251204065
R-HSA-977441	GABA A receptor activation	 10	0.0883599329364341	0.30936993975749	7	3	7527	9675	1.59920361029997
R-HSA-977443	GABA receptor activation	 46	0.158310555807735	0.431588389037009	24	22	7510	9656	1.19195300146582
R-HSA-977444	GABA B receptor activation	 35	0.34179660606728	0.697503539125671	17	18	7517	9660	1.10965148469794
R-HSA-977606	Regulation of Complement cascade	 39	0.999965242559794	1	6	33	7528	9645	0.351473320945049
R-HSA-982772	Growth hormone receptor signaling	 21	0.280867226542441	0.621004072544232	11	10	7523	9668	1.19668297369386
R-HSA-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	 22	0.819529001771798	1	8	14	7526	9664	0.830755122233752
R-HSA-983189	Kinesins	 42	0.719595862885465	1	17	25	7517	9653	0.924709570581617
R-HSA-983695	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	 48	0.766675371994165	1	19	29	7515	9649	0.904311565348199
R-HSA-991365	Activation of GABAB receptors	 35	0.34179660606728	0.697503539125671	17	18	7517	9660	1.10965148469794
R-HSA-997269	Inhibition of adenylate cyclase pathway	 13	0.967259494222963	1	3	10	7531	9668	0.527209981417574
R-HSA-997272	Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits	 22	0.0485079765817369	0.22626312000252	14	8	7520	9670	1.45382146390907
